Unnamed: 0,title,date,stock,sentiment
590377.0,"Oppenheimer Maintains Outperform on GW Pharmaceuticals, Lowers Price Target to $166",2020-06-01 11:47:00-04:00,GWPH,negative
590378.0,7 High-Risk Stocks For Market Gamblers,2020-05-28 14:55:00-04:00,GWPH,neutral
590379.0,Cannabis Short Sellers Down $641M In May,2020-05-22 10:26:00-04:00,GWPH,neutral
590380.0,"Cramer Gives His Opinion On GW Pharma, Bed Bath & Beyond And More",2020-05-21 07:56:00-04:00,GWPH,neutral
590381.0,10 Biggest Price Target Changes For Thursday,2020-05-14 08:00:00-04:00,GWPH,neutral
590382.0,"Cantor Fitzgerald Maintains Overweight on GW Pharmaceuticals, Raises Price Target to $154",2020-05-14 06:40:00-04:00,GWPH,negative
590383.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,GWPH,negative
590384.0,"The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings",2020-05-12 08:06:00-04:00,GWPH,negative
590385.0,"GW Pharmaceuticals Q2 EPS $(0.020) Beats $(0.850) Estimate, Sales $120.535M Beat $108.360M Estimate",2020-05-11 16:00:00-04:00,GWPH,neutral
590386.0,Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week,2020-05-11 10:25:00-04:00,GWPH,positive
590387.0,Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week,2020-05-11 09:49:00-04:00,GWPH,positive
590388.0,"The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight",2020-05-10 15:40:00-04:00,GWPH,neutral
590389.0,"Cannabis Stock Gainers And Losers From May 4, 2020",2020-05-04 16:44:00-04:00,GWPH,negative
590390.0,"ESPAÑOL • Noticias del Día: Vendedores en Corto de Cannabis Sufren, High Times Compra Dispensarios por $80M, Hablamos con Seth Rogen, y Más",2020-04-28 17:44:00-04:00,GWPH,neutral
590391.0,Cannabis Stock Rally Puts Short Sellers In The Red For 2020,2020-04-28 10:33:00-04:00,GWPH,neutral
590392.0,CBD Companies Receive FDA Warnings For Promoting Unauthorized Products,2020-04-26 18:18:00-04:00,GWPH,positive
590393.0,"Cannabis Stock Gainers And Losers From April 20, 2020",2020-04-20 17:35:00-04:00,GWPH,negative
590394.0,"Cannabis Stock Gainers And Losers From April, 17, 2020",2020-04-17 17:29:00-04:00,GWPH,negative
590395.0,ESPAÑOL •  Empresas de Cannabis con Acciones el NYSE y NASDAQ: Una Lista Completa,2020-04-14 13:47:00-04:00,GWPH,neutral
590396.0,"ESPAÑOL • Notas Del Día: Charlotte Figi, Epidiolex, Acciones, La Iglesia del Cannabis, Psicodélicos para Salud Mental, y Más",2020-04-13 16:05:00-04:00,GWPH,neutral
590397.0,Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week,2020-04-13 11:15:00-04:00,GWPH,positive
590398.0,"The Week In Cannabis: Charlotte Figi's Passing, Epidiolex's De-Scheduling, Stocks Up And More",2020-04-12 09:25:00-04:00,GWPH,neutral
590399.0,"ESPAÑOL • Noticias Del Día: Cannabis Para Insomnio, Epidiolex, Autismo, Marihuana Legal, Seedo, AOC, Y Más",2020-04-09 12:13:00-04:00,GWPH,positive
590400.0,A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies,2020-04-09 09:50:00-04:00,GWPH,neutral
590401.0,"Cannabis Stock Gainers And Losers From April 8, 2020",2020-04-08 17:06:00-04:00,GWPH,negative
590402.0,"Northland Capital Markets Initiates Coverage On GW Pharmaceuticals with Outperform Rating, Announces Price Target to $128",2020-04-08 11:24:00-04:00,GWPH,neutral
590403.0,"Cannabis Stock Gainers And Losers From April 7, 2020",2020-04-07 17:02:00-04:00,GWPH,negative
590404.0,DEA Deschedules Expidiolex; GW Pharma's CBD Epilepsy Treatment No Longer A Controlled Substance,2020-04-07 11:11:00-04:00,GWPH,negative
590405.0,Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week,2020-04-06 10:47:00-04:00,GWPH,positive
590406.0,"GW Pharma Reports EPIDIOLEX Oral Solution Has Been Descheduled, Is No Longer A Controlled Substance",2020-04-06 09:00:00-04:00,GWPH,neutral
590407.0,"The Week In Cannabis: Stocks Back In The Red, CannTrust Enters Creditor Protection, Good News For MedMen, GW Pharma",2020-04-05 13:25:00-04:00,GWPH,positive
590408.0,GW Pharma Vet Ethan Russo Launches Endocannabinoid Startup,2020-04-02 13:00:00-04:00,GWPH,neutral
590409.0,FDA Grants GW Pharmaceuticals Priority Review For Cannabidiol Drug In Seizure Condition,2020-04-01 12:20:00-04:00,GWPH,positive
590410.0,GW Pharmaceuticals And Greenwich Biosciences Announce FDA Acceptance Of sNDA Filing With Priority Review For EPIDIOLEX In Treatment Of Seizures Associated With Tuberous Sclerosis Complex,2020-03-31 07:17:00-04:00,GWPH,positive
590411.0,"Cannabis Stock Gainers And Losers From March 26, 2020",2020-03-26 17:37:00-04:00,GWPH,negative
590412.0,"Cannabis Stock Gainers And Losers From March 23, 2020",2020-03-23 18:54:00-04:00,GWPH,negative
590413.0,"Cannabis Stock Gainers And Losers From March 18, 2020",2020-03-18 17:02:00-04:00,GWPH,negative
590414.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,GWPH,positive
590415.0,10 Small-To-Mid-Cap Biotech Ideas For When The Coronavirus Fades,2020-03-17 17:13:00-04:00,GWPH,neutral
590416.0,"Cannabis Stock Gainers And Losers From March 17, 2020",2020-03-17 16:50:00-04:00,GWPH,negative
590417.0,"Cannabis Stock Gainers And Losers From March 16, 2020",2020-03-16 19:39:00-04:00,GWPH,negative
590418.0,"The Week In Cannabis: Coronavirus Drop, Major Financing Agreements, Psychedelics Getting Hot",2020-03-14 08:53:00-04:00,GWPH,neutral
590419.0,"Cannabis Stock Gainers And Losers From March 13, 2020",2020-03-13 17:43:00-04:00,GWPH,negative
590420.0,GW Pharma Submits CBD Seizure Treatment To European Medicines Agency For Approval,2020-03-13 10:23:00-04:00,GWPH,positive
590421.0,GW Pharma Reports Submission Of Type II Variation Application To EMA To Expand Use Of EPIDYOLEX For Treatment Of Seizures Associated With Tuberous Sclerosis Complex,2020-03-13 07:15:00-04:00,GWPH,positive
590422.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,GWPH,negative
590423.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,GWPH,negative
590424.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,GWPH,positive
590425.0,"Cannabis Stock Gainers And Losers From March, 10. 2020",2020-03-10 19:40:00-04:00,GWPH,negative
590426.0,Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week,2020-03-09 09:29:00-04:00,GWPH,positive
590427.0,"Benzinga's Top Upgrades, Downgrades For March 6, 2020",2020-03-06 09:39:00-05:00,GWPH,positive
590428.0,"Citigroup Initiates Coverage On GW Pharmaceuticals with Buy Rating, Announces $192 Price Target",2020-03-06 05:08:00-05:00,GWPH,neutral
590429.0,GW Pharma Obtains Exclusive UK Commercialization Rights To Sativex From Bayer,2020-03-02 13:38:00-05:00,GWPH,positive
590430.0,The Week In Cannabis: A Bunch Of Earnings And Policy Moves Around The World,2020-03-02 13:23:00-05:00,GWPH,neutral
590431.0,GW Pharmaceuticals Regains Exclusive Commercialization Rights to Sativex in the UK from Bayer,2020-03-02 05:38:00-05:00,GWPH,positive
590432.0,10 Biggest Price Target Changes For Thursday,2020-02-27 08:27:00-05:00,GWPH,neutral
590433.0,"H.C. Wainwright Reiterates Buy on GW Pharmaceuticals, Lowers Price Target to $161",2020-02-27 07:25:00-05:00,GWPH,negative
590434.0,"GW Pharma's Epidiolex Label Expansion, EU Launch Key Growth Drivers In 2020",2020-02-26 13:55:00-05:00,GWPH,positive
590435.0,"B of A Securities Maintains Buy on GW Pharmaceuticals, Lowers Price Target to $227",2020-02-26 12:40:00-05:00,GWPH,positive
590436.0,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",2020-02-26 09:36:00-05:00,GWPH,negative
590437.0,GW Pharmaceuticals shares are trading lower after multiple firms lowered their respective price targets on the stock.,2020-02-26 09:18:00-05:00,GWPH,positive
590438.0,"Oppenheimer Maintains Outperform on GW Pharmaceuticals, Lowers Price Target to $173",2020-02-26 08:12:00-05:00,GWPH,negative
590439.0,"Needham Maintains Buy on GW Pharmaceuticals, Lowers Price Target to $190",2020-02-26 06:17:00-05:00,GWPH,negative
590440.0,"GW Pharmaceuticals Q1 EPS $(0.07) Beats $(0.75) Estimate, Sales $109.076M Beat $105.1M Estimate",2020-02-25 16:13:00-05:00,GWPH,neutral
590441.0,"The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement",2020-02-25 08:28:00-05:00,GWPH,negative
590442.0,"Cannabis Stock Gainers And Losers From Feb. 24, 2020",2020-02-25 07:13:00-05:00,GWPH,negative
590443.0,The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace,2020-02-23 18:38:00-05:00,GWPH,neutral
590444.0,"Cannabis Stock Gainers And Losers From Feb. 21, 2020",2020-02-21 18:11:00-05:00,GWPH,negative
590445.0,"Cannabis Stock Gainers And Losers From Feb. 20, 2020",2020-02-21 09:32:00-05:00,GWPH,negative
590446.0,"Cannabis Stock Gainers And Losers From Feb. 19, 2020",2020-02-19 16:58:00-05:00,GWPH,negative
590447.0,Can CBD Help With Opioid  Withdrawal? Johns Hopkins Researchers Aim To Find Out By Testing Epidiolex in This Context,2020-02-18 12:55:00-05:00,GWPH,positive
590448.0,Cannabis Countdown: Top 10 Marijuana Industry News Stories Of The Week,2020-02-10 08:56:00-05:00,GWPH,positive
590449.0,"The Week In Cannabis: Corporate Turmoil, Mass Layoffs And Stocks In Red",2020-02-09 15:45:00-05:00,GWPH,negative
590450.0,This Company Was Surprisingly Named S&P Global's Most Sustainable Brand In Cannabis,2020-02-07 08:45:00-05:00,GWPH,positive
590451.0,"The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",2020-02-07 07:32:00-05:00,GWPH,negative
590452.0,BofA Sees Blockbuster Sales Potential For GW Pharma's CBD Drug Epidiolex,2020-02-04 12:02:00-05:00,GWPH,positive
590453.0,Cannabis Countdown: Top 10 Marijuana Industry News Stories Of The Week,2020-02-03 09:08:00-05:00,GWPH,positive
590454.0,GW Pharmaceuticals and Greenwich Biosciences Submit Supplemental New Drug Application to the FDA for Epidiolex for the Treatment of Tuberous Sclerosis Complex,2020-02-03 07:10:00-05:00,GWPH,neutral
590455.0,Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week,2020-01-20 08:48:00-05:00,GWPH,positive
590456.0,The Week In Cannabis: Stocks Rebound Hard And Many More News,2020-01-19 12:37:00-05:00,GWPH,negative
590457.0,GW Pharma Analyst Expects $475M In Sales Of CBD Drug Expidiolex This Year,2020-01-16 12:16:00-05:00,GWPH,neutral
590458.0,From JP Morgan Healthcare Conference: GW Pharma CEO Sees Filing Application For Expanded US Approval Of Epilepsy Drug 'In Coming Week's,2020-01-14 14:22:00-05:00,GWPH,positive
590459.0,"GW Pharma Reports Preliminary Q4 Revenue Of $108M, 'Exceptional' Launch Year For Epidiolex",2020-01-13 11:54:00-05:00,GWPH,neutral
590460.0,GW Pharmaceuticals FY 2019 Preliminary Net Product Sales $309M vs $302.06M Est; Q4 Net Product Sales of $108M vs $100.17M Est,2020-01-12 19:19:00-05:00,GWPH,neutral
590461.0,"Benzinga's Top Upgrades, Downgrades For January 2, 2020",2020-01-02 10:42:00-05:00,GWPH,positive
590462.0,Open Source Medicine And Cannabinoids: A Promising Future,2019-12-27 14:01:00-05:00,GWPH,positive
590463.0,"Cannabis Stock Gainers And Losers From Dec. 19, 2019",2019-12-19 16:39:00-05:00,GWPH,negative
590464.0,"Cannabis Stock Gainers And Losers From Dec. 18, 2019",2019-12-18 16:59:00-05:00,GWPH,negative
590465.0,"Hearing Leerink Out Positive On GW Pharmaceuticals, Sees 80% Upside And Estimates Peak US Sales For Epidiolex Of ~$1.5B",2019-12-18 14:10:00-05:00,GWPH,positive
590466.0,"Cannabis Stock Gainers And Losers From Dec. 17, 2019",2019-12-17 18:26:00-05:00,GWPH,negative
590467.0,"Cannabis Stock Gainers And Losers From December 12, 2019",2019-12-12 17:19:00-05:00,GWPH,negative
590468.0,"Cannabis Stock Gainers And Losers From Dec. 11, 2019",2019-12-11 16:34:00-05:00,GWPH,negative
590469.0,"Cramer Advises His Viewers On GW Pharma, Enphase And More",2019-12-11 11:12:00-05:00,GWPH,neutral
590470.0,"Greenwich Biosciences, a GW Pharmaceuticals Company, Presents New Data for EPIDIOLEX in Patients with Tuberous Sclerosis Complex at AES 2019",2019-12-07 14:25:00-05:00,GWPH,neutral
590471.0,"'Exceeded Our Expectations': First Latin American Study On CBD, Epilepsy Completed",2019-12-07 08:50:00-05:00,GWPH,neutral
590472.0,"Cannabis Stock Gainers And Losers From Dec. 5, 2019",2019-12-05 16:10:00-05:00,GWPH,negative
590473.0,GW Pharmaceuticals Option Alert: Dec 20 $170 Calls Sweep (3) near the Ask: 3300 @ $0.35 vs 3338 OI; Ref=$106.2046,2019-12-04 15:07:00-05:00,GWPH,positive
590474.0,"Cannabis Stock Gainers And Losers From Dec. 2, 2019",2019-12-02 16:12:00-05:00,GWPH,negative
590475.0,"The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More",2019-12-01 09:30:00-05:00,GWPH,neutral
590476.0,"Cannabis Stock Gainers And Losers From Nov. 27, 2019",2019-11-27 16:53:00-05:00,GWPH,negative
590477.0,"Cannabis Stock Gainers And Losers From Nov. 26, 2019",2019-11-26 17:03:00-05:00,GWPH,negative
590478.0,"Brace For Stricter FDA Regulation Of CBD Consumer Products, Analysts Say",2019-11-26 16:45:00-05:00,GWPH,neutral
590479.0,"Cannabis Stock Gainers And Losers From Nov. 25, 2019",2019-11-25 16:30:00-05:00,GWPH,negative
590480.0,Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week,2019-11-25 09:26:00-05:00,GWPH,positive
590481.0,"Cannabis Stock Gainers And Losers From November 22, 2019",2019-11-22 16:48:00-05:00,GWPH,negative
590482.0,Are We Experiencing A Cannabis Bubble? Lessons From The Dotcom Days,2019-11-21 17:26:00-05:00,GWPH,neutral
590483.0,"Cannabis Stock Gainers And Losers From November 21, 2019",2019-11-21 16:17:00-05:00,GWPH,negative
590484.0,Cannabis Short Sellers Down $272M Following Canopy Growth Upgrade,2019-11-21 11:05:00-05:00,GWPH,positive
590485.0,"Cannabis Stock Gainers And Losers From Nov. 19, 2019",2019-11-19 16:18:00-05:00,GWPH,negative
590486.0,"Shares of cannabis companies are trading higher, rebounding from recent weakness following large sell offs. NOTE: The sector has been heavily volatile in recent weeks.",2019-11-19 10:37:00-05:00,GWPH,negative
590487.0,"Cannabis Stock Gainers And Losers From November 18, 2019",2019-11-18 16:13:00-05:00,GWPH,negative
590488.0,Shares of several cannabis companies are trading lower in sympathy with Aurora Cannabis after the company announced last week that it would cancel/delay plans for multiple facility expansions and converted some debt into shares in order to conserve cash.,2019-11-18 11:48:00-05:00,GWPH,positive
590489.0,"The Week In Cannabis: Stocks Fall On Poor Earnings, More Americans Support Legalization",2019-11-15 17:12:00-05:00,GWPH,neutral
590490.0,"Cannabis Stock Gainers And Losers From November 15, 2019",2019-11-15 16:38:00-05:00,GWPH,negative
590491.0,"Cannabis Stock Gainers And Losers From November 14, 2019",2019-11-14 16:09:00-05:00,GWPH,negative
590492.0,"Analyst: New UK Cannabis Regulations Limit Usage, Call For Additional Research",2019-11-14 15:49:00-05:00,GWPH,neutral
590493.0,"Cannabis Stock Gainers And Losers From November 13, 2019",2019-11-13 16:20:00-05:00,GWPH,negative
590494.0,UK Recommends NHS Reimburse GW Pharma's CBD-Based Epilepsy Drug,2019-11-12 18:37:00-05:00,GWPH,positive
590495.0,"Cannabis Stock Gainers And Losers From November 12, 2019",2019-11-12 16:53:00-05:00,GWPH,negative
590496.0,Cannabis Short Sellers Up Another $190M In November,2019-11-12 14:01:00-05:00,GWPH,neutral
590497.0,Tuesday's Market Minute: The Greenest Week Of Earnings,2019-11-12 09:41:00-05:00,GWPH,neutral
590498.0,"Cannabis Stock Gainers And Losers From November 11, 2019",2019-11-11 16:51:00-05:00,GWPH,negative
590499.0,"GW Pharmaceuticals Receives Positive NICE recommendation for EPIDYOLEX Oral Solution for the Treatment of Seizures in Patients With Two Rare, Severe Forms of Childhood-onset Epilepsy",2019-11-10 19:35:00-05:00,GWPH,positive
590500.0,"The Week In Cannabis: Drake And Tony Hawk Get In The Weeds, Linton Joins Vireo, And A Myriad Of Earnings",2019-11-08 17:10:00-05:00,GWPH,neutral
590501.0,"Cannabis Stock Gainers And Losers From November 8, 2019",2019-11-08 16:30:00-05:00,GWPH,negative
590502.0,"Cannabis Stock Gainers And Losers From November 7, 2019",2019-11-07 16:48:00-05:00,GWPH,negative
590503.0,60 Biggest Movers From Yesterday,2019-11-07 05:44:00-05:00,GWPH,neutral
590504.0,"Cannabis Stock Gainers And Losers From November 6, 2019",2019-11-06 16:33:00-05:00,GWPH,negative
590505.0,62 Stocks Moving In Wednesday's Mid-Day Session,2019-11-06 13:48:00-05:00,GWPH,neutral
590506.0,Analysts Remain Upbeat On GW Pharma's Optionality With Epidiolex,2019-11-06 13:45:00-05:00,GWPH,neutral
590507.0,10 Biggest Price Target Changes For Wednesday,2019-11-06 08:32:00-05:00,GWPH,neutral
590508.0,"The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings",2019-11-06 08:21:00-05:00,GWPH,positive
590509.0,17 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-11-06 07:52:00-05:00,GWPH,neutral
590510.0,28 Stocks Moving in Wednesday's Pre-Market Session,2019-11-06 07:24:00-05:00,GWPH,neutral
590511.0,"Cantor Fitzgerald Maintains Overweight on GW Pharmaceuticals, Lowers Price Target to $174",2019-11-06 06:56:00-05:00,GWPH,negative
590512.0,GW Pharmaceuticals PLC shares are trading lower after the company reported Q3 earnings results.,2019-11-05 16:52:00-05:00,GWPH,neutral
590513.0,"GW Pharmaceuticals Reports Q3 Sales Beat, Stock Falls",2019-11-05 16:35:00-05:00,GWPH,neutral
590514.0,"GW Pharmaceuticals Q3 EPS $(0.04) May Not Compare To $(0.87) Estimate, Sales $90.971M Beat $85.91M Estimate",2019-11-05 16:18:00-05:00,GWPH,neutral
590515.0,"Cannabis Stock Gainers And Losers From November 5, 2019",2019-11-05 16:08:00-05:00,GWPH,negative
590516.0,GW Pharmaceuticals Q4 Earnings Outlook,2019-11-05 07:19:00-05:00,GWPH,neutral
590517.0,"The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment",2019-11-05 06:53:00-05:00,GWPH,negative
590518.0,"Cannabis Stock Gainers And Losers From November 4, 2019",2019-11-04 16:17:00-05:00,GWPH,negative
590519.0,"The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight",2019-11-03 10:51:00-05:00,GWPH,neutral
590520.0,"Cramer Gives His Take On Slack, CME Group And More",2019-11-01 12:37:00-04:00,GWPH,neutral
590521.0,"Benzinga's Top Upgrades, Downgrades For October 30, 2019",2019-10-30 10:34:00-04:00,GWPH,positive
590522.0,"H.C. Wainwright Initiates Coverage On GW Pharmaceuticals with Buy Rating, Announces $170 Price Target",2019-10-30 07:10:00-04:00,GWPH,neutral
590523.0,"Cannabis Stock Gainers And Losers From October 29, 2019",2019-10-29 16:28:00-04:00,GWPH,negative
590524.0,"Cannabis Stock Gainers And Losers From October 28, 2019",2019-10-28 17:13:00-04:00,GWPH,negative
590525.0,"Cannabis Stock Gainers And Losers From October 24, 2019",2019-10-24 16:35:00-04:00,GWPH,negative
590526.0,Ask Our Experts: What Are The Top CBD Companies On The Market?,2019-10-24 10:11:00-04:00,GWPH,positive
590527.0,"Cannabis Stock Gainers And Losers From October 22, 2019",2019-10-22 16:40:00-04:00,GWPH,negative
590528.0,"Cannabis Stock Gainers And Losers From October 21, 2019",2019-10-21 16:47:00-04:00,GWPH,negative
590529.0,"Needham Earlier Initiated Coverage On GW Pharmaceuticals with Buy Rating, Announced $200 Price Target",2019-10-21 10:54:00-04:00,GWPH,neutral
590530.0,"Cannabis Stock Gainers And Losers From October 17, 2019",2019-10-18 07:04:00-04:00,GWPH,negative
590531.0,"Cannabis Stock Gainers And Losers From October 16, 2019",2019-10-16 16:30:00-04:00,GWPH,negative
590532.0,"Jim Cramer Gives His Opinion On Disney, Carnival Corp And More",2019-10-08 11:43:00-04:00,GWPH,neutral
590533.0,Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week,2019-10-07 10:27:00-04:00,GWPH,positive
590534.0,Cannabis Short Sellers Bank $200M In Two Days,2019-10-01 15:00:00-04:00,GWPH,neutral
590535.0,Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week,2019-09-30 10:10:00-04:00,GWPH,positive
590536.0,'Renewed Sense Of Hope': GW Pharma CEO Talks Epilepsy Drug Approval In Europe,2019-09-25 13:59:00-04:00,GWPH,positive
590537.0,23 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-09-25 08:17:00-04:00,GWPH,neutral
590538.0,GW Pharma's CBD Seizure Drug Epidiolex Approved In Europe As Adjunctive Therapy,2019-09-23 08:42:00-04:00,GWPH,positive
590539.0,"GW Pharmaceuticals Receives European Commission Approval for EPIDYOLEX for the Treatment of Seizures in Patients with Two Rare, Severe Forms of Childhood-Onset Epilepsy",2019-09-23 07:06:00-04:00,GWPH,positive
590540.0,Teva Dips Into Medical Marijuana Market With Canndoc Distribution Deal,2019-09-13 08:14:00-04:00,GWPH,neutral
590541.0,14 Top Cannabis Stocks Targeted By Short Sellers,2019-09-11 10:47:00-04:00,GWPH,positive
590542.0,"Cannabis Stock Gainers And Losers From September 10, 2019",2019-09-10 16:27:00-04:00,GWPH,negative
590543.0,"Jim Cramer Shares His Thoughts On Netflix, Beyond Meat And More",2019-09-06 11:14:00-04:00,GWPH,positive
590544.0,Cannabis Countdown: Top 10 Marijuana Industry News Stories Of The Week,2019-09-03 08:43:00-04:00,GWPH,positive
590545.0,"The Week In Cannabis: Moves From The DEA, FDA, USDA; New York Fashion Week; And Quarterly Reports",2019-09-01 17:56:00-04:00,GWPH,neutral
590546.0,"UK NHS Says Epidiolex Too Expensive, GW Pharma Says Company 'Remains Hopeful'",2019-08-29 14:16:00-04:00,GWPH,positive
590547.0,"Cannabis Stock Gainers And Losers From August 20, 2019",2019-08-20 16:21:00-04:00,GWPH,negative
590548.0,"Cannabis Stock Gainers And Losers From August 19, 2019",2019-08-19 16:10:00-04:00,GWPH,negative
590549.0,"Cannabis Stock Gainers And Losers From August 16, 2019",2019-08-17 13:43:00-04:00,GWPH,negative
590550.0,Early Success Of CBD Drug Looms Large For The Industry's Future,2019-08-15 10:18:00-04:00,GWPH,positive
590551.0,Cannabis Short Sellers Clean Up After Tilray's Earnings Miss,2019-08-15 09:36:00-04:00,GWPH,positive
590552.0,"Cannabis Stock Gainers And Losers From August 14, 2019",2019-08-14 16:13:00-04:00,GWPH,negative
590553.0,"Cannabis Stock Gainers And Losers From August 13, 2019",2019-08-13 16:17:00-04:00,GWPH,negative
590554.0,"Cannabis Stock Gainers, Losers From August 12, 2019",2019-08-12 16:34:00-04:00,GWPH,negative
590555.0,"The Week In Cannabis: CannTrust Rallies Unexpectedly, Josh Kushner And Shane Victorino Join The Industry, And More",2019-08-11 14:46:00-04:00,GWPH,positive
590556.0,"Cannabis Stock Gainers And Losers From August 9, 2019",2019-08-09 16:18:00-04:00,GWPH,negative
590557.0,"Cannabis Stock Gainers And Losers From August 8, 2019",2019-08-08 16:15:00-04:00,GWPH,negative
590558.0,Cramer: Epidiolex Maker GW Pharma Is Far From A 'Sketchy' Weed Business,2019-08-08 13:16:00-04:00,GWPH,neutral
590559.0,"Cannabis Stock Gainers And Losers From August 6, 2019",2019-08-07 16:16:00-04:00,GWPH,negative
590560.0,GW Pharma Analysts Raise Estimates After CBD Drug Epidiolex Shows Strong Uptake,2019-08-07 11:47:00-04:00,GWPH,positive
590561.0,"AT&T, Disney And More 'Fast Money' Picks For August 7",2019-08-07 10:34:00-04:00,GWPH,neutral
590562.0,GW Pharmaceuticals shares are trading higher after the company reported Q2 EPS up from last year and better-than-expected Q2 sales results.,2019-08-07 09:06:00-04:00,GWPH,positive
590563.0,40 Stocks Moving In Wednesday's Pre-Market Session,2019-08-07 07:46:00-04:00,GWPH,neutral
590564.0,"The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",2019-08-07 07:34:00-04:00,GWPH,neutral
590565.0,5 Stocks Moving In Tuesday's After-Hours Session,2019-08-06 16:35:00-04:00,GWPH,neutral
590566.0,"Cannabis Stock Gainers And Losers From August 6, 2019",2019-08-06 16:15:00-04:00,GWPH,negative
590567.0,GW Pharmaceuticals shares are trading higher after the company reported a 184% increase in Q2 EPS from last year and better-than-expected sales results.,2019-08-06 16:08:00-04:00,GWPH,positive
590568.0,"GW Pharma Rallies On Strong Q2 Epidiolex Sales, Says European Approval Expected In October",2019-08-06 16:08:00-04:00,GWPH,positive
590569.0,"GW Pharmaceuticals Q2 EPS $0.21 Up From $(0.25) YoY, Sales $72.038M Beat $47.05M Estimate",2019-08-06 16:05:00-04:00,GWPH,neutral
590570.0,Shares of several Cannabis companies are trading higher in sympathy with Aurora Cannabis after the company issued strong Q4 sales guidance.,2019-08-06 11:26:00-04:00,GWPH,positive
590571.0,"The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering",2019-08-06 07:22:00-04:00,GWPH,positive
590572.0,"Cannabis Stock Gainers And Losers From August 5, 2019",2019-08-05 16:13:00-04:00,GWPH,negative
590573.0,"The Week Ahead In Cannabis: Cronos And GW Pharma Earnings, Ontario's Second License Lottery",2019-08-05 08:13:00-04:00,GWPH,neutral
590574.0,"The Week Ahead In Biotech: Focus On Earnings Deluge, Mid-Year Clinical Trial Readouts",2019-08-03 10:18:00-04:00,GWPH,neutral
590575.0,Cannabis Stocks Are The Latest Target Of Short Sellers,2019-08-02 13:41:00-04:00,GWPH,neutral
590576.0,FDA Can't Figure Out How To Regulate CBD - And It Doesn't Really Want To,2019-08-02 12:46:00-04:00,GWPH,negative
590577.0,"Cannabis Stock Gainers And Losers From August 1, 2019",2019-08-01 16:12:00-04:00,GWPH,negative
590578.0,"Cannabis Stock Gainers And Losers From July 31, 2019",2019-07-31 16:05:00-04:00,GWPH,negative
590579.0,"Cannabis Stock Gainers And Losers From July 30, 2019",2019-07-30 16:17:00-04:00,GWPH,negative
590580.0,What To Know About The Senate Hearing On Hemp,2019-07-30 16:11:00-04:00,GWPH,neutral
590581.0,"Cannabis Stock Gainers And Losers From July 29, 2019",2019-07-29 16:33:00-04:00,GWPH,negative
590582.0,"The Week In Cannabis: Tobacco And Retail Stray In The Weeds, Congress Holds SAFE Banking Hearings, New ETFs, And More",2019-07-28 15:51:00-04:00,GWPH,positive
590583.0,"Cannabis Stock Gainers And Losers From July 26, 2019",2019-07-26 16:26:00-04:00,GWPH,negative
590584.0,GW Pharma Receives EU Regulatory Agency Panel Backing For Epidiolex,2019-07-26 10:48:00-04:00,GWPH,neutral
590585.0,"GW Pharma Reports Received Positive CHMP Opinion For EPIDYOLEX For The Treatment Of Seizures In Patients With 2 Rare, Severe Forms Of Childhood-Onset Epilepsy",2019-07-26 06:42:00-04:00,GWPH,positive
590586.0,"Cannabis Stock Gainers And Losers From July 25, 2019",2019-07-25 16:22:00-04:00,GWPH,negative
590587.0,"Cannabis Stock Gainers And Losers From July 24, 2019",2019-07-24 16:09:00-04:00,GWPH,negative
590588.0,"Cannabis Stock Gainers And Losers From July 23, 2019",2019-07-23 16:30:00-04:00,GWPH,negative
590589.0,"Jim Cramer Weighs In On Berkshire Hathaway, Range Resources, Zynerba And More",2019-07-23 07:41:00-04:00,GWPH,neutral
590590.0,"Cannabis Stock Gainers And Losers From July 22, 2019",2019-07-22 16:18:00-04:00,GWPH,negative
590591.0,"Cannabis Stock Gainers And Losers From July 19, 2019",2019-07-19 16:25:00-04:00,GWPH,negative
590592.0,"Cannabis Stock Gainers And Losers From July 18, 2019",2019-07-18 16:15:00-04:00,GWPH,negative
590593.0,"Cannabis Stocks Gainers And Losers From July 17, 2019",2019-07-17 16:17:00-04:00,GWPH,negative
590594.0,6 Cannabis Market Predictions That Are Already Coming True,2019-07-17 11:37:00-04:00,GWPH,positive
590595.0,"Cannabis Stock Gainers And Losers From July 16, 2019",2019-07-16 16:30:00-04:00,GWPH,negative
590596.0,"Cannabis Stocks Gainers and Losers From July 15, 2019",2019-07-15 16:21:00-04:00,GWPH,negative
590597.0,"Cannabis Stock Gainers And Losers From July 12, 2019",2019-07-12 16:21:00-04:00,GWPH,negative
590598.0,"Cannabis Stock Gainers And Losers From July 11, 2019",2019-07-11 16:19:00-04:00,GWPH,negative
590599.0,"Cannabis Stock Gainers And Losers From July 10, 2019",2019-07-10 16:24:00-04:00,GWPH,negative
590600.0,"NYSE And NASDAQ Cannabis Stock Gainers And Losers From July 9, 2019",2019-07-09 16:22:00-04:00,GWPH,negative
590601.0,GW Pharmaceuticals Option Alert: Jul 19 $185 Calls Sweep (3) near the Ask: 500 @ $1.0 vs 1059 OI; Earnings 8/6 After Close [est] Ref=$176.21,2019-07-09 10:15:00-04:00,GWPH,positive
590602.0,Another Cannabis ETF Sparks Up Today,2019-07-09 06:05:00-04:00,GWPH,neutral
590603.0,"Cannabis Stock Gainers And Losers From July 8, 2019",2019-07-08 16:40:00-04:00,GWPH,negative
590604.0,"The Week In Cannabis: Canopy Growth Trims Bruce Linton, Congressional Hearings On Ending Marijuana Prohibition, And More",2019-07-07 14:11:00-04:00,GWPH,positive
590605.0,"Cannabis Stock Gainers And Losers From July 3, 2019",2019-07-03 13:46:00-04:00,GWPH,negative
590606.0,Cannabis Stocks With Plenty Of Green Ahead,2019-07-03 13:15:00-04:00,GWPH,neutral
590607.0,"Cannabis Stock Gainers And Losers From July 2, 2019",2019-07-02 16:29:00-04:00,GWPH,negative
590608.0,"Cannabis Stocks Gainers and Losers From July 1, 2019",2019-07-01 16:35:00-04:00,GWPH,negative
590609.0,"The Week In Cannabis: Illinois Goes Rec, Federal Commerce And Banking Bills, Surterra's $100M Raise And More",2019-06-30 10:37:00-04:00,GWPH,neutral
590610.0,Cannabis Stocks Gainers and Losers from June 28,2019-06-28 16:32:00-04:00,GWPH,negative
590611.0,Meet The 3 Biggest Industries Investing In Cannabis,2019-06-28 15:51:00-04:00,GWPH,neutral
590612.0,Cannabis Stock Gainers And Losers From June 27,2019-06-27 16:28:00-04:00,GWPH,negative
590613.0,Cannabis Stock Gainers And Losers From June 26,2019-06-26 16:29:00-04:00,GWPH,negative
590614.0,"But, Which Spectrum? What You Need To Know About Hemp And Its Chemical Compounds",2019-06-26 15:57:00-04:00,GWPH,neutral
590615.0,Cannabis Stock Gainers And Losers From June 25,2019-06-25 16:24:00-04:00,GWPH,negative
590616.0,Cannabis Stock Gainers And Losers From June 24,2019-06-24 17:37:00-04:00,GWPH,negative
590617.0,"The Week In Cannabis: House Takes Historic Vote, New York Decriminalizes, Woman-Led Company Lists On Nasdaq, And More",2019-06-23 15:12:00-04:00,GWPH,neutral
590618.0,Cannabis Stock Gainers And Losers From June 21,2019-06-21 18:10:00-04:00,GWPH,negative
590619.0,"10 Cannabis Products To Try This Summer: Hi-Fi Hops, Sun Lotion And More",2019-06-21 09:48:00-04:00,GWPH,neutral
590620.0,Cannabis Stock Gainers And Losers From June 20,2019-06-20 16:25:00-04:00,GWPH,negative
590621.0,"BDS Analytics, Arcview Project $40B In Global Cannabis Spending By 2024",2019-06-20 08:34:00-04:00,GWPH,neutral
590622.0,Cannabis Stock Gainers And Losers From June 19,2019-06-19 16:45:00-04:00,GWPH,negative
590623.0,Cannabis Stock Gainers And Losers From June 17,2019-06-17 16:33:00-04:00,GWPH,negative
590624.0,"The Week In Cannabis: Colorado Hits $1B In Sales, Harborside In Canada, Kroger Embraces CBD, And More",2019-06-16 09:11:00-04:00,GWPH,neutral
590625.0,"Cannabis Stock Gainers, Losers From June 14",2019-06-14 18:00:00-04:00,GWPH,negative
590626.0,Cannabis Stock Gainers And Losers From June 13,2019-06-13 16:20:00-04:00,GWPH,negative
590627.0,Cannabis Stock Gainers And Losers From June 11,2019-06-11 16:21:00-04:00,GWPH,negative
590628.0,Cannabis Stock Gainers And Losers From June 10,2019-06-10 16:13:00-04:00,GWPH,negative
590629.0,"The Week In Cannabis: Gillibrand's Legalization Plan, Analyst Ratings, South Africa's CBD Store, And Some Legal News",2019-06-09 15:13:00-04:00,GWPH,positive
590630.0,Cannabis Stock Gainers And Losers From June 6,2019-06-06 16:21:00-04:00,GWPH,negative
590631.0,"FDA Public Hearing About CBDs Prescribes Caution, Bearishness, and Deliberation",2019-06-06 10:56:00-04:00,GWPH,neutral
590632.0,Cannabis Stock Gainers And Losers From June 5,2019-06-05 16:16:00-04:00,GWPH,negative
590633.0,Cannabis Stock Gainers And Losers From June 4,2019-06-04 17:27:00-04:00,GWPH,negative
590634.0,Cannabis Stock Gainers And Losers From June 3,2019-06-03 16:21:00-04:00,GWPH,negative
590635.0,"The Week In Cannabis: Earnings Madness, Illinois Legalization, FDA Hearing, And More",2019-06-02 16:05:00-04:00,GWPH,negative
590636.0,Cannabis Stock Gainers And Losers From May 31,2019-05-31 16:54:00-04:00,GWPH,negative
590637.0,Cannabis Stock Gainers And Losers From May 30,2019-05-30 16:34:00-04:00,GWPH,negative
590638.0,Cannabis Stock Gainers And Losers From May 29,2019-05-29 16:28:00-04:00,GWPH,negative
590639.0,Cannabis Stock Gainers And Losers From May 28,2019-05-28 16:15:00-04:00,GWPH,negative
590640.0,"The Week In Cannabis: Canada Funds Research, EU Country Allows Sale Of CBD, NFL Moves Forward",2019-05-26 15:57:00-04:00,GWPH,neutral
590641.0,Cannabis Stock Gainers and Losers From May 24,2019-05-24 16:51:00-04:00,GWPH,negative
590642.0,The Blooming Weed Industry Explained In Charts And Maps: Storefronts And Deliveries By The Numbers,2019-05-24 15:58:00-04:00,GWPH,neutral
590643.0,Cannabis Stock Gainers And Losers From May 23,2019-05-23 16:52:00-04:00,GWPH,negative
590644.0,The Blooming Weed Industry Explained In Hiring And Growth Charts,2019-05-23 14:12:00-04:00,GWPH,positive
590645.0,"The Week In Cannabis: Big Earnings Reports, Biden's Change Of Heart, New Report On Dispensaries",2019-05-19 15:22:00-04:00,GWPH,neutral
590646.0,"The Week In Cannabis: A&F Tries CBD, GW Pharma Soars On Results, Denver Decriminalizes Mushrooms",2019-05-12 09:22:00-04:00,GWPH,neutral
590647.0,"The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split",2019-05-08 07:53:00-04:00,GWPH,negative
590648.0,64 Stocks Moving In Tuesday's Mid-Day Session,2019-05-07 12:17:00-04:00,GWPH,neutral
590649.0,"Analysts Raise Price Targets On GW Pharma's Positive Earnings, Epidiolex Results",2019-05-07 11:40:00-04:00,GWPH,positive
590650.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tues., May 7, 2019",2019-05-07 10:46:00-04:00,GWPH,positive
590651.0,"UPDATE: Piper Jaffray Raises GW Pharmaceuticals Target To $210, Reiterates Overweight As Firm Notes 'Epidiolex launch is going strong and we expect momentum to continue'",2019-05-07 10:39:00-04:00,GWPH,positive
590652.0,"Piper Jaffray Reiterates Overweight on GW Pharmaceuticals Plc - American Depositary Shares, Raises Price Target to $210",2019-05-07 10:32:00-04:00,GWPH,negative
590653.0,UPDATE: JP Morgan Raises GW Pharmaceuticals Tgt To $215 As Firm Believes 'Epidiolex is on track to come in north of $150M in its first full year (with off label use being a major potential swing factor)' Easily Exceeding Firm's Initial Expectations,2019-05-07 10:29:00-04:00,GWPH,positive
590654.0,GW Pharma's CBD Drug Epidiolex Could Secure Label Expansion Following Positive Trial Results,2019-05-07 10:23:00-04:00,GWPH,positive
590655.0,10 Biggest Price Target Changes For Tuesday,2019-05-07 09:40:00-04:00,GWPH,neutral
590656.0,GW Pharmaceuticals PLC shares are trading higher after the company reported positive results from an Epidiolex trial.,2019-05-07 09:30:00-04:00,GWPH,positive
590657.0,"Benzinga's Top Upgrades, Downgrades For May 7, 2019",2019-05-07 09:07:00-04:00,GWPH,positive
590658.0,"The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex",2019-05-07 08:20:00-04:00,GWPH,neutral
590659.0,31 Stocks Moving In Tuesday's Pre-Market Session,2019-05-07 08:05:00-04:00,GWPH,neutral
590660.0,"Jim Cramer Shares His Thoughts On Blackstone, General Dynamics, GW Pharma And More",2019-05-07 07:53:00-04:00,GWPH,positive
590661.0,"JP Morgan Maintains Overweight on GW Pharmaceuticals Plc - American Depositary Shares, Raises Price Target to $215",2019-05-07 07:41:00-04:00,GWPH,positive
590662.0,Oppenheimer Upgrades GW Pharmaceuticals Plc - American Depositary Shares to Outperform,2019-05-07 06:57:00-04:00,GWPH,positive
590663.0,"GW Pharmaceuticals Q2 EPS $(0.14) Up From $(0.2) YoY, Sales $39.25M Beat $17.33M Estimate",2019-05-06 16:29:00-04:00,GWPH,neutral
590664.0,GW Pharma Reports Phase 3 Pivotal Trial Results For EPIDIOLEX Oral Solution In Patients With Seizures Associated With Tuberous Sclerosis Complex:  Achieved Primary Efficacy Measure,2019-05-06 16:02:00-04:00,GWPH,positive
590665.0,GW Pharmaceuticals Q2 Earnings Preview,2019-05-06 09:14:00-04:00,GWPH,neutral
590666.0,"The Week In Cannabis News: Curaleaf Buys Cura Partners, Canopy Buys C3, Organigram Applies For Nasdaq Listing",2019-05-05 14:15:00-04:00,GWPH,neutral
590667.0,Edison Research Sees $140B Potential In Cannabis,2019-05-04 17:44:00-04:00,GWPH,neutral
590668.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs",2019-05-04 16:56:00-04:00,GWPH,neutral
590669.0,"The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen",2019-05-03 07:49:00-04:00,GWPH,positive
590670.0,5 Biotech Stocks With Near-Term Catalysts Ahead,2019-05-02 14:18:00-04:00,GWPH,neutral
590671.0,"GW Pharmaceuticals Will Present Data From The Pivotal Phase 3 Trials Of Epidiolex Oral Solution, Cv In Lennox-Gastaut Syndrome And Dravet Syndrome, Along With Other Supportive Data, At The American Academy Of Neurology Annual Meeting, May 4-10",2019-05-02 08:58:00-04:00,GWPH,positive
590672.0,"The Week In Cannabis: Conferences, Clean Slate Act, Earnings, Aurora, Canopy-Acreage And More",2019-04-28 11:25:00-04:00,GWPH,positive
590673.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs",2019-04-27 11:44:00-04:00,GWPH,neutral
590674.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,GWPH,positive
590675.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-18 10:51:00-04:00,GWPH,negative
590676.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-17 10:31:00-04:00,GWPH,negative
590677.0,Shares of several drug companies are trading lower. Weakness may be tied to uncertainty over healthcare policy going into the 2020 primaries and Washington's recent efforts to curb prescription drug prices.,2019-04-16 15:34:00-04:00,GWPH,negative
590678.0,"The Week In Cannabis News: SAFE Banking Act In The Senate, Greenlane's IPO, B-Real, Canopy Growth And More",2019-04-14 13:23:00-04:00,GWPH,positive
590679.0,Bulls And Bud Of The Week: CB2 Insights And Dr. Kerklaan's Therapeutics,2019-04-10 12:54:00-04:00,GWPH,neutral
590680.0,FDA Rejects Regulatory Filing For Zogenix Epilepsy Drug; GW Pharma Moves In Sympathy,2019-04-09 09:05:00-04:00,GWPH,negative
590681.0,"The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing",2019-04-09 08:10:00-04:00,GWPH,neutral
590682.0,28 Stocks Moving In Tuesday's Pre-Market Session,2019-04-09 07:59:00-04:00,GWPH,neutral
590683.0,"GW Pharma shares trading higher in opposition to Zogenix shares. Following news Zogenix received a refusal to file letter from the FDA for its drug candidate to treat seizures related to Dravet Syndrome, traders may be viewing GW as a sympathy play.",2019-04-08 16:13:00-04:00,GWPH,positive
590684.0,GW Pharma Shares Trading Up 3.9% Following Zogenix News Co. Received Refusal To File Letter From FDA Related To Treatment Of Seizures Related To Dravet Syndrome,2019-04-08 16:09:00-04:00,GWPH,positive
590685.0,"This Week's Cannabis News: The FDA And CBD, The STATES Act, Cresco And Origin House, Europe And High Times",2019-04-07 16:07:00-04:00,GWPH,neutral
590686.0,Where Will Tilray's Stock Find Technical Support?,2019-04-04 15:16:00-04:00,GWPH,positive
590687.0,"FDA Schedules First Public Hearing On CBD, Sends Warning Letters To 3 Companies",2019-04-03 14:56:00-04:00,GWPH,negative
590688.0,"The Week In Cannabis: SAFE(er) Banking, New Jersey, Seth Rogen, Walgreens And Earnings",2019-03-31 16:40:00-04:00,GWPH,neutral
590689.0,"Walgreens Joins CVS, Will Start Selling CBD Products In Select Stores",2019-03-27 14:35:00-04:00,GWPH,neutral
590690.0,"The Week In Cannabis: SAFE Banking Act, Stocks In Red, IPOs, High Tech Agro Projects And Celebs In Marijuana",2019-03-23 15:36:00-04:00,GWPH,positive
590691.0,"Vape Distributor Greenlane Holdings Files S-1 Form, Plans NASDAQ IPO",2019-03-21 13:47:00-04:00,GWPH,neutral
590692.0,GW Pharmaceuticals Announces The Sale Of Priority Review Voucher For $105M,2019-03-18 07:30:00-04:00,GWPH,neutral
590693.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-03-15 17:00:00-04:00,GWPH,positive
590694.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-03-08 16:05:00-05:00,GWPH,positive
590695.0,5 Cannabis And CBD Stocks That Aren't Blowing Smoke,2019-03-08 07:50:00-05:00,GWPH,neutral
590696.0,CBD Vs. THC: The Science Behind The Most Popular Cannabinoids,2019-03-07 16:45:00-05:00,GWPH,positive
590697.0,"Piper Jaffray: Tilray, GW Pharma Are Early Leaders In Medical Cannabis",2019-03-05 14:13:00-05:00,GWPH,neutral
590698.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-03-01 16:32:00-05:00,GWPH,positive
590699.0,84 Biggest Movers From Yesterday,2019-02-28 05:10:00-05:00,GWPH,neutral
590700.0,Cantor Reiterates Bullish View On GW Pharmaceuticals Following Earnings,2019-02-27 16:14:00-05:00,GWPH,neutral
590701.0,72 Stocks Moving In Wednesday's Mid-Day Session,2019-02-27 12:20:00-05:00,GWPH,neutral
590702.0,GW Pharmaceuticals PLC shares are trading higher after the company beat Q1 sales estimates.,2019-02-27 09:38:00-05:00,GWPH,positive
590703.0,35 Stocks Moving In Wednesday's Pre-Market Session,2019-02-27 08:25:00-05:00,GWPH,neutral
590704.0,"The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings",2019-02-27 08:13:00-05:00,GWPH,neutral
590705.0,GW Pharmaceuticals Sees 68% Q1 Revenue Growth Following Epidiolex Launch,2019-02-26 16:40:00-05:00,GWPH,positive
590706.0,"GW Pharmaceuticals Q1 EPS $(0.20), Sales $6.654M Beat $5.35M Estimate",2019-02-26 16:18:00-05:00,GWPH,neutral
590707.0,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",2019-02-26 07:56:00-05:00,GWPH,positive
590708.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-02-22 18:07:00-05:00,GWPH,positive
590709.0,Thailand Legalizes Medical Weed: What's Next?,2019-02-22 16:48:00-05:00,GWPH,neutral
590710.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-02-22 13:55:00-05:00,GWPH,neutral
590711.0,Guggenheim Initiates Coverage On GW Pharmaceuticals with Buy Rating,2019-02-22 10:21:00-05:00,GWPH,neutral
590712.0,New York City Bans CBD Edibles: What Now?,2019-02-20 15:01:00-05:00,GWPH,neutral
590713.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-02-15 16:31:00-05:00,GWPH,positive
590714.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-02-08 18:28:00-05:00,GWPH,positive
590715.0,420 Investor: GW Pharma Investors May Have To Wait Out Short-Term Volatility,2019-02-04 15:26:00-05:00,GWPH,neutral
590716.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-02-03 10:01:00-05:00,GWPH,positive
590717.0,Jim Cramer Shares His Predictions For The Cannabis Industry,2019-01-29 13:24:00-05:00,GWPH,positive
590718.0,Wall Street's Favorite Cannabis Stock,2019-01-29 08:30:00-05:00,GWPH,positive
590719.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-01-25 16:07:00-05:00,GWPH,positive
590720.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-01-21 09:56:00-05:00,GWPH,positive
590721.0,"Jim Cramer Advises His Viewers On Brink's, Medtronic And More",2019-01-18 07:43:00-05:00,GWPH,neutral
590722.0,Bank Of America Names GWPH Top SMid-Cap Biotech For 1H19 As Firm Notes 'continued strong feedback from prescribing physicians on the new Epidiolex launch' And Firm Is Confident 'in the long term potential for sales in' Dravet And Lennox-Gastaut Syndrome,2019-01-16 08:45:00-05:00,GWPH,positive
590723.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-01-11 18:06:00-05:00,GWPH,positive
590724.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-01-04 16:00:00-05:00,GWPH,positive
590725.0,26 Stocks Moving In Thursday's Pre-Market Session,2019-01-03 08:23:00-05:00,GWPH,neutral
590726.0,"JP Morgan Initiates Coverage On GW Pharmaceuticals with Overweight Rating, Announces $134 Price Target",2019-01-02 09:31:00-05:00,GWPH,neutral
590727.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-12-28 16:54:00-05:00,GWPH,positive
590728.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-12-21 16:53:00-05:00,GWPH,positive
590729.0,FDA Warms To Considering Legal Cannabis Ingredients In Food,2018-12-21 10:50:00-05:00,GWPH,positive
590730.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,GWPH,neutral
590731.0,Biotechs Were Innovators In 2018: Here Are The Top New Molecules That Were Approved,2018-12-18 08:55:00-05:00,GWPH,positive
590732.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-12-14 18:59:00-05:00,GWPH,positive
590733.0,"Benzinga's Top Upgrades, Downgrades For December 12, 2018",2018-12-12 09:28:00-05:00,GWPH,positive
590734.0,"Oppenheimer Initiates Coverage On GW Pharmaceuticals with Perform Rating, Announces $142 Price Target",2018-12-12 08:23:00-05:00,GWPH,neutral
590735.0,The 2018 Farm Bill Vote: What You Need To Know,2018-12-11 16:11:00-05:00,GWPH,neutral
590736.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-12-07 16:09:00-05:00,GWPH,positive
590737.0,"Bank Of America Bullish On GW Pharma, Expects Growth In Epidiolex Sales",2018-12-04 12:20:00-05:00,GWPH,positive
590738.0,Cantor Fitzgerald Lowers GW Pharmaceuticals Price Target,2018-12-03 15:01:00-05:00,GWPH,negative
590739.0,10 Biggest Price Target Changes For Monday,2018-12-03 10:12:00-05:00,GWPH,neutral
590740.0,"Cantor Fitzgerald Maintains Overweight on GW Pharmaceuticals, Lowers Price Target to $193",2018-12-03 07:43:00-05:00,GWPH,negative
590741.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs",2018-12-02 17:51:00-05:00,GWPH,neutral
590742.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-11-30 16:43:00-05:00,GWPH,positive
590743.0,"Cantor Fitzgerald Bullish On GW Pharmaceuticals, Sees 75% Upside Potential",2018-11-28 15:11:00-05:00,GWPH,neutral
590744.0,22 Stocks Moving In Wednesday's Pre-Market Session,2018-11-28 08:12:00-05:00,GWPH,neutral
590745.0,"The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings",2018-11-28 07:46:00-05:00,GWPH,neutral
590746.0,GW Pharmaceuticals shares are trading down 5.3% after the company missed Q4 revenue estimates.,2018-11-27 17:00:00-05:00,GWPH,neutral
590747.0,"GW Pharma Beats Q4 EPS Estimates, Misses On Revenue",2018-11-27 16:47:00-05:00,GWPH,negative
590748.0,"GW Pharmaceuticals Plc - American Depositary Shares Q4 EPS $(0.23) Beats $(2.46) Estimate, Sales $2.42M Miss $5.48M Estimate",2018-11-27 16:00:00-05:00,GWPH,positive
590749.0,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",2018-11-27 07:32:00-05:00,GWPH,negative
590750.0,GW Pharmaceuticals Q4 Earnings Preview,2018-11-27 07:26:00-05:00,GWPH,neutral
590751.0,"Earnings Scheduled For November 27, 2018",2018-11-27 04:48:00-05:00,GWPH,neutral
590752.0,"Additional Late-Stage Study Confirms Efficacy, Safety Of GW Pharma's Epidiolex",2018-11-26 09:53:00-05:00,GWPH,positive
590753.0,GW Pharma's Second Phase 3 Pivotal Trial for EPIDIOLEX Has Met its Primary Endpoint,2018-11-26 07:05:00-05:00,GWPH,neutral
590754.0,"The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings",2018-11-25 09:41:00-05:00,GWPH,neutral
590755.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-11-23 16:54:00-05:00,GWPH,positive
590756.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-11-17 15:53:00-05:00,GWPH,positive
590757.0,What Is CBD — And How Can Investors Take Advantage Of It?,2018-11-15 15:00:00-05:00,GWPH,positive
590758.0,4 Reasons Why Leerink Is Bullish On GW Pharma,2018-11-14 12:43:00-05:00,GWPH,neutral
590759.0,"Benzinga's Top Upgrades, Downgrades For November 13, 2018",2018-11-13 09:18:00-05:00,GWPH,positive
590760.0,"Leerink Swann Initiates Coverage On GW Pharmaceuticals with Outperform Rating, Announces $185 Price Target",2018-11-13 08:48:00-05:00,GWPH,neutral
590761.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-11-09 16:44:00-05:00,GWPH,positive
590762.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-11-02 16:13:00-04:00,GWPH,positive
590763.0,Experts Weigh In On Medical Cannabis Products Now Available In The UK,2018-11-02 15:13:00-04:00,GWPH,neutral
590764.0,"GW Pharmaceuticals Reports EPIDIOLEX Oral Solution, A Cannabinoid Medicine, Is Now Available By Prescription In US",2018-11-01 08:28:00-04:00,GWPH,positive
590765.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-10-26 16:22:00-04:00,GWPH,positive
590766.0,Short Sellers Are Making Huge Profits In Cannabis Stocks,2018-10-26 14:00:00-04:00,GWPH,positive
590767.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-10-19 16:22:00-04:00,GWPH,positive
590768.0,'Study of U.S. hospital figures links cannabis use with increased risk of stroke' -Canada's Globe And Mail,2018-10-19 10:08:00-04:00,GWPH,neutral
590769.0,Cannabis Stocks Largely Down On Canada's First Day Of Legal Leaf,2018-10-17 16:05:00-04:00,GWPH,positive
590770.0,"The '420 Investor' Talks Canada's Legalization, Calls Cannabis Stocks A Crowded Trade Right Now",2018-10-17 13:07:00-04:00,GWPH,neutral
590771.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-10-12 16:33:00-04:00,GWPH,positive
590772.0,Watch Volatility In Cannabis-Related Stocks Following Aphria Earnings,2018-10-12 07:09:00-04:00,GWPH,neutral
590773.0,'UK to allow doctors to prescribe cannabis-based medicine' -The Guardian,2018-10-11 10:01:00-04:00,GWPH,positive
590774.0,"Morgan Stanley Maintains Overweight on GW Pharmaceuticals, Lowers Price Target to $227",2018-10-11 09:24:00-04:00,GWPH,negative
590775.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-10-05 18:22:00-04:00,GWPH,positive
590776.0,"The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares",2018-10-03 07:54:00-04:00,GWPH,positive
590777.0,GW Pharmaceuticals Prices 1.9M ADS Public Offering @$158/ADS,2018-10-03 03:57:00-04:00,GWPH,neutral
590778.0,"The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares",2018-10-02 09:10:00-04:00,GWPH,positive
590779.0,GW Pharma Reports $300M Offering Of ADSs,2018-10-01 16:02:00-04:00,GWPH,neutral
590780.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-09-28 16:31:00-04:00,GWPH,positive
590781.0,D.E.A. Today Issued Official Final Order Rescheduling GW Pharma's Epidiolex as a Schedule V Substance; This Was Reported Yesterday,2018-09-28 11:40:00-04:00,GWPH,neutral
590782.0,51 Biggest Movers From Yesterday,2018-09-28 05:15:00-04:00,GWPH,neutral
590783.0,GW Pharma Shares Unaffected Following CNBC Interview With Co. CEO,2018-09-27 13:52:00-04:00,GWPH,positive
590784.0,GW Pharma Shares Up 6.5% Midday As Co. CEO Beginning CNBC Interview Now,2018-09-27 13:46:00-04:00,GWPH,positive
590785.0,36 Stocks Moving In Thursday's Mid-Day Session,2018-09-27 12:37:00-04:00,GWPH,neutral
590786.0,GW Pharma's Epidiolex Becomes First CBD To Get DEA Rescheduling,2018-09-27 11:19:00-04:00,GWPH,neutral
590787.0,"GW Pharmaceuticals shares are up 9.6% to $178.27 after the DEA rescheduled the company's EPIDIOLEX (Cannabidiol) oral solution to schedule V, the lowest restriction classification by the DEA.",2018-09-27 10:16:00-04:00,GWPH,negative
590788.0,UPDATE: Alan Brochstein Tells Benzinga He Doesn't See Positive Readthrough for Zynerba Pharma From The DEA's Rescheduling of Peer GW Pharma's CBD Drug,2018-09-27 09:57:00-04:00,GWPH,negative
590789.0,"420 Investor Alan Brochstein Tells Benzinga of the DEA's Landmark Rescheduling of GW Pharma's Epidiolex: 'Great news, but expected for the most part. Now, it's game on for the company.'",2018-09-27 09:57:00-04:00,GWPH,positive
590790.0,"GW Pharmaceuticals And Its US Subsidiary Announce DEA Has Rescheduled EPIDIOLEX (Cannabidiol) Oral Solution To Schedule V, The Lowest Restriction Classification By The DEA",2018-09-27 09:28:00-04:00,GWPH,negative
590791.0,"GW Pharma Shares Indicated Up 8% Premarket On Light Volume (~3K Shares); Traders Earlier Circulated NBC WTHR 13 Article 'New CBD oil drug is first in U.S. recognized as legal under federal law', Referring To GW Pharma's Epidiolex",2018-09-27 08:52:00-04:00,GWPH,positive
590792.0,High Times Buys DOPE Magazine For $11M: Here's Why And What It Means For The Cannabis Industry,2018-09-26 15:02:00-04:00,GWPH,neutral
590793.0,Top 12 Cannabis Stocks By Market Cap One-Year Stock Price Performance,2018-09-26 10:04:00-04:00,GWPH,positive
590794.0,Navigating The Maze Of The Cannabis Market After The Daze Of Summer,2018-09-25 11:05:00-04:00,GWPH,negative
590795.0,New York Governor Cuomo Reportedly Signs Legislation That Adds Acute Pain Management To List Of Conditions For Which Medical Marijuana Can Be Recommended As An Alternative To Opioid Use.,2018-09-24 14:51:00-04:00,GWPH,negative
590796.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-09-21 20:38:00-04:00,GWPH,positive
590797.0,"The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Snags BARDA Funding",2018-09-21 08:51:00-04:00,GWPH,negative
590798.0,"Stocks Which Set New 52-Week High Yesterday, September 20th",2018-09-21 08:16:00-04:00,GWPH,neutral
590799.0,"Stocks Which Set New 52-Week High Yesterday, September 19th",2018-09-20 11:24:00-04:00,GWPH,neutral
590800.0,"Cannabinoid Biotech Stocks Higher After Morgan Stanley Earlier Said the U.S. DEA Is Expected This Week To Reclassify GW Pharma's CBD Epidiolex For Medicinal Use; GW Pharma Shares Up 5.8%, Peer Zynerba Pharma Shares Up 5.1%",2018-09-19 11:26:00-04:00,GWPH,positive
590801.0,Morgan Stanley: DEA Likely To Reclassify GW Pharma's Cannabinoid Therapy For US Launch,2018-09-19 09:16:00-04:00,GWPH,neutral
590802.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-09-14 17:42:00-04:00,GWPH,positive
590803.0,"Zogenix Has $3.4B Opportunity With Pediatric Epilepsy Asset, BofA Says In Bullish Initiation",2018-09-14 09:37:00-04:00,GWPH,positive
590804.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-09-07 19:13:00-04:00,GWPH,positive
590805.0,"Morgan Stanley Reinstates Overweight on GW Pharmaceuticals, Announces $197 Price Target",2018-09-07 07:47:00-04:00,GWPH,negative
590806.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-08-31 16:08:00-04:00,GWPH,positive
590807.0,"Marijuana Stocks Appear Unaffected Amid Comment From Long-Known Cannabis Proponent, Vincente Fox, Former President Of Mexico: 'Marijuana Should Be Part Of NAFTA'",2018-08-30 11:13:00-04:00,GWPH,neutral
590808.0,Tilray's First Earnings Print Gives Cannabis Stocks Another Boost,2018-08-29 15:02:00-04:00,GWPH,positive
590809.0,5 Books To Read Before Investing In Cannabis,2018-08-29 12:47:00-04:00,GWPH,neutral
590810.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-08-24 18:09:00-04:00,GWPH,positive
590811.0,Sticker Shock: Is GW Pharmaceutical's Epidiolex Really That Expensive?,2018-08-22 11:30:00-04:00,GWPH,negative
590812.0,Everything You Need To Know From The Cannabis Capital Conference,2018-08-22 08:47:00-04:00,GWPH,neutral
590813.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-08-19 12:28:00-04:00,GWPH,positive
590814.0,"Stifel Bullish On GW Pharma, Sees $1.5 Billion In Epidiolex Sales By 2023",2018-08-15 11:29:00-04:00,GWPH,neutral
590815.0,"Q2 13F Roundup: How Buffett, Einhorn, Loeb And Others Adjusted Their Portfolio",2018-08-15 10:23:00-04:00,GWPH,neutral
590816.0,5 Cannabis Stocks Getting A Boost From Canopy Growth's Big Investment,2018-08-15 09:23:00-04:00,GWPH,positive
590817.0,"Benzinga's Top Upgrades, Downgrades For August 15, 2018",2018-08-15 09:10:00-04:00,GWPH,positive
590818.0,"Stifel Nicolaus Initiates Coverage On GW Pharmaceuticals with Buy Rating, Announces $181 Price Target",2018-08-15 06:54:00-04:00,GWPH,neutral
590819.0,"13F Filing From Omega Shows Dissolved 70K Share Stake In GW Pharma, Dissolved 182.5K Stake In Hudson",2018-08-14 11:15:00-04:00,GWPH,positive
590820.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-08-10 16:31:00-04:00,GWPH,positive
590821.0,"GW Pharmaceuticals Q3 EPS $(1.63) Beats $(2.67) Estimate, Sales $4.47M Beat $2.93M Estimate",2018-08-07 16:05:00-04:00,GWPH,neutral
590822.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,GWPH,negative
590823.0,36 Stocks Moving In Tuesday's Pre-Market Session,2018-08-07 08:04:00-04:00,GWPH,neutral
590824.0,CBD Poses Both Opportunities And Obstacles For The Cannabis Industry,2018-08-06 09:49:00-04:00,GWPH,neutral
590825.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-08-03 17:16:00-04:00,GWPH,positive
590826.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-07-27 15:31:00-04:00,GWPH,positive
590827.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-07-20 16:18:00-04:00,GWPH,positive
590828.0,Women Execs React To Cannabis Trends Report Highlighting The Rise Of Females In The Marijuana Industry,2018-07-17 15:00:00-04:00,GWPH,neutral
590829.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-07-13 16:41:00-04:00,GWPH,positive
590830.0,4 Questions With Cannabics Pharmaceuticals CEO Eyal Barad,2018-07-13 12:40:00-04:00,GWPH,neutral
590831.0,Zogenix Soars On Positive Phase 3 Data In Dravet Syndrome Study,2018-07-12 08:47:00-04:00,GWPH,positive
590832.0,"GW Pharmaceuticals Down 3% Premarket After Zogenix Announces Positive Outcome Of ZX008 Trial; ZX008 Is Rival To GW's Epidiolex, A Cannabis-Based Seizure Treatment",2018-07-12 08:18:00-04:00,GWPH,positive
590833.0,5 Hot Pot Stocks In 2018 And 5 More To Watch The Rest Of The Year,2018-07-10 07:38:00-04:00,GWPH,neutral
590834.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-07-06 17:37:00-04:00,GWPH,positive
590835.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-06-29 15:48:00-04:00,GWPH,positive
590836.0,"Marijuana Stocks Broadly Lower Today; Cronos Group -8.1%, GW Pharma -6.9%, Zynerba -8.9%, Alternative Harvest ETF -4.6%",2018-06-27 13:42:00-04:00,GWPH,negative
590837.0,GW Pharmaceuticals' FDA Win Reinforces BofA's Bullish Thesis,2018-06-26 15:50:00-04:00,GWPH,positive
590838.0,420 Investor: Cannabis Drug Approval Creates 'Logic Issue' For The US Government,2018-06-26 13:10:00-04:00,GWPH,positive
590839.0,GW Pharmaceuticals CEO To Appear On CNBC's Power Lunch,2018-06-26 11:34:00-04:00,GWPH,neutral
590840.0,"Bank of America Maintains Buy on GW Pharmaceuticals, Raises Price Target to $200",2018-06-26 10:18:00-04:00,GWPH,neutral
590841.0,"The Market In 5 Minutes: GE Spin-Offs, Instagram's Worth, The Permian Basin And More",2018-06-26 09:17:00-04:00,GWPH,positive
590842.0,"Benzinga's Daily Biotech Pulse: Epidiolex, Roche's Influenza Drug Gets Priority Review Status, Xeris Jumps On Positive Trial Results",2018-06-26 08:34:00-04:00,GWPH,positive
590843.0,"420 Investor's Alan Brochstein, On Benzinga's PreMarket Prep, Says GW Pharma Will Raise Cash, 'They Don't Need To' But They Should Raise More Cash, 'Look Whats Going On In Canada'",2018-06-26 08:23:00-04:00,GWPH,neutral
590844.0,The 420 Investor's Alan Brochstein Currently Discussing GW Pharma And Epidiolex On Benzinga's PreMarket Prep,2018-06-26 08:17:00-04:00,GWPH,neutral
590845.0,Cantor Fitzgerald Raises GW Pharma's Target To $235 Following Epidiolex Approval,2018-06-25 15:57:00-04:00,GWPH,positive
590846.0,"Hearing Cantor Fitzgerald Has Raised GW Pharma Price Target To Street High $205, Unconfirmed",2018-06-25 14:08:00-04:00,GWPH,negative
590847.0,"The Week Ahead: Senate Weighs Sprint-T-Mobile Merger, Nike Earnings And A Slew Of IPOs",2018-06-25 14:00:00-04:00,GWPH,neutral
590848.0,"Downside In GW Pharma Intensifies As $150 Level Breaks Down; Shares Down 2% Over Last Few Mins., Stock Now Down 2.7% For Session",2018-06-25 13:21:00-04:00,GWPH,positive
590849.0,GW Pharma's Epidiolex Becomes First Cannabis-Based FDA-Approved Drug,2018-06-25 13:06:00-04:00,GWPH,neutral
590850.0,"'$GWPH says it will take @DEAHQ ""within 90 days"" to schedule Epidiolex, so drug could go on sale this fall'-WSJ's Jonathan Rockoff Tweets",2018-06-25 13:03:00-04:00,GWPH,neutral
590851.0,"'FDA sends pre-emptive warning to anyone trying to peddle unapproved uses of medical marijuana or cannabidiol, now that $GWPH approved @SGottliebFDA statement'-STAT's Adam Feuerstein Tweets",2018-06-25 12:47:00-04:00,GWPH,negative
590852.0,"BZ NOTE: Despite FDA Approval For GW Pharma's Epidiolex, Before Co. Can Market Epidiolex The U.S. DEA Will Have To Reclassify Cannabidiol",2018-06-25 12:43:00-04:00,GWPH,negative
590853.0,"GW Pharma Shares Now At New Session Low, Down 1.4% For Session; Shares Initially Spiked 5% As Traders First Circulated FDA.gov Doc Showing Approval For Epidiolex In Dravet Syndrome",2018-06-25 12:33:00-04:00,GWPH,positive
590854.0,BZ NOTE: Watch Shares of Cannabinoid Peer Zynerba Pharma Amid FDA Approval For GW Pharma's Epidiolex,2018-06-25 12:27:00-04:00,GWPH,positive
590855.0,GW Pharma Receives FDA Approval Of NDA For Epidiolex,2018-06-25 12:25:00-04:00,GWPH,positive
590857.0,"REMINDER Stocks With FDA Actions Expected This Week Include: Achaogen PDUFA Date for Plazomicin 6/25, Durect and Pain Therapeutics AdCom For Remoxy June 26, & GW Pharma PDUFA For Epidiolex in LG Syndrome June 27",2018-06-25 05:12:00-04:00,GWPH,negative
590858.0,"The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs",2018-06-24 10:43:00-04:00,GWPH,neutral
590859.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-06-22 16:20:00-04:00,GWPH,positive
590860.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-06-15 16:35:00-04:00,GWPH,positive
590861.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-06-08 16:48:00-04:00,GWPH,positive
590862.0,From Undefeated UFC Champion To Cannabis Entrepreneur: The Frank Shamrock Story,2018-06-07 13:45:00-04:00,GWPH,positive
590863.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-06-01 16:03:00-04:00,GWPH,positive
590864.0,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,2018-06-01 13:22:00-04:00,GWPH,neutral
590865.0,"Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA",2018-05-30 08:14:00-04:00,GWPH,positive
590866.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-05-27 11:38:00-04:00,GWPH,positive
590867.0,Cannabis Hedge Fund Managers On The Two Biggest Problems Marijuana Businesses Face,2018-05-25 13:46:00-04:00,GWPH,negative
590868.0,5 Cannabis Stocks That Have Been Outperforming,2018-05-23 15:51:00-04:00,GWPH,neutral
590869.0,Here's Why The Marijuana ETF Could Be A Short-Covering Idea,2018-05-23 12:54:00-04:00,GWPH,neutral
590870.0,How One Company Is Capitalizing On Cannabis Distillates' Surging Popularity,2018-05-21 14:31:00-04:00,GWPH,positive
590871.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-05-18 17:14:00-04:00,GWPH,positive
590872.0,"Benzinga's Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More",2018-05-17 08:27:00-04:00,GWPH,neutral
590873.0,GW Pharma's Epidiolex Featured In Daily Mail Article 'Cannabis oil could treat epilepsy: Landmark study reveals it can reduce the severity of fits by more than 40%',2018-05-17 07:27:00-04:00,GWPH,positive
590874.0,GW Pharma Reports Publication In NEJM Phase 3 Study Of Epidiolex In Lennox-Gastaut Syndrome: Both Evaluated Doses Significantly Reduced Monthly Frequency Of Drop Seizures vs Placebo,2018-05-16 17:03:00-04:00,GWPH,negative
590875.0,Marijuana In College: Why Universities Are Offering Cannabis-Focused Classes (And Where You Can Find Them),2018-05-15 12:05:00-04:00,GWPH,neutral
590876.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-05-11 17:43:00-04:00,GWPH,positive
590877.0,"Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway",2018-05-09 07:48:00-04:00,GWPH,neutral
590878.0,"GW Pharmaceuticals Q2 EPS $(3.12) Misses $(2.48) Estimate, Sales $3.351M Beat $3.02M Estimate",2018-05-08 16:01:00-04:00,GWPH,negative
590879.0,"Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure",2018-05-08 07:55:00-04:00,GWPH,neutral
590880.0,AxisWire: The Birth Of A Cannabis Industry Media Standard,2018-05-07 09:58:00-04:00,GWPH,neutral
590881.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry",2018-05-07 08:14:00-04:00,GWPH,positive
590882.0,Why Cannabis Investors Are Eyeing South America,2018-05-03 13:42:00-04:00,GWPH,neutral
590883.0,"Jim Cramer Weighs In On Snap, Seagate And More",2018-05-03 07:52:00-04:00,GWPH,neutral
590884.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-04-29 09:06:00-04:00,GWPH,positive
590885.0,"Pot Stocks, ETFs And Top News From The Cannabis Industry This Week",2018-04-20 16:16:00-04:00,GWPH,positive
590886.0,"'Decriminalizing Cannabis Is Long Overdue': Politicians, Experts React To Chuck Schumer's Marijuana Bill",2018-04-20 11:58:00-04:00,GWPH,neutral
590887.0,"10 Cannabis Products, 8 Fun Events And A New Album To Celebrate 4/20",2018-04-20 09:11:00-04:00,GWPH,positive
590888.0,"The Market In 5 Minutes: Oil, Amazon, GW Pharma And More",2018-04-20 09:09:00-04:00,GWPH,positive
590889.0,'An Incredible Signal': 4 Experts Weigh In On Positive FDA Panel Vote For GW Pharma's Epidiolex,2018-04-19 16:37:00-04:00,GWPH,positive
590890.0,"GW Pharma Shares Rebound Off Session Lows, Now Up 2.5% Over Last Few Mins Following Conclusion Of CNBC Appearance By Co. CEO Gover",2018-04-19 14:44:00-04:00,GWPH,positive
590891.0,GW Pharma Shares Down 0.3% For Session Following Appearance By CEO Gover On CNBC,2018-04-19 14:41:00-04:00,GWPH,positive
590892.0,Watching GW Pharma Shares As Co. CEO Justin Gover Currently Interview With Meg Tirrell On CNBC,2018-04-19 14:39:00-04:00,GWPH,positive
590893.0,Cara Therapeutics Shares Down 1.3% Since Resumption Of GW Pharma Shares; Cara Has Been Perceived As Peer Play To GW Pharma Given An Early-Stage Dravet Syndrome Candidate,2018-04-19 13:26:00-04:00,GWPH,positive
590894.0,Zynerba Shares Fell 3.8% Following Resumption Of Trade In GW Pharma,2018-04-19 13:23:00-04:00,GWPH,positive
590895.0,"GW Pharmaceuticals Resume Trade, Now Up 2% At $136.63/Share",2018-04-19 13:15:00-04:00,GWPH,neutral
590896.0,GW Pharma Shares To Resume Trade At 1:15 p.m. EDT,2018-04-19 12:48:00-04:00,GWPH,positive
590897.0,"UPDATE: GW Pharma Reports FDA PDUFA Date For NDA for Epidiolex In Dravet and Lennox-Gastaut Syndromes Is June 27th, 2018",2018-04-19 12:46:00-04:00,GWPH,neutral
590898.0,GW Pharma Issues Release Confirm Unanimous Positive Result Of FDA AdCom Meeting For Epidiolex,2018-04-19 12:45:00-04:00,GWPH,positive
590899.0,Zynerba Shares Up 9.4% On News Of Positive AdCom Vote for Peer GW Pharma's Epidiolex,2018-04-19 11:52:00-04:00,GWPH,positive
590900.0,'$GWPH gets unanimous 13-0 vote from outside panel of advisers to FDA that benefit-risk profile of Epidiolex is favorable for treatment of childhood epilepsies'-CNBC's Meg Tirrell Tweet,2018-04-19 11:43:00-04:00,GWPH,positive
590901.0,FDA Panel Unanimously Votes To Say Benefits Of Co.'s Cannabis-Derived Treatment For Severe Childhood Epilepsy Outweigh Its Risks,2018-04-19 11:41:00-04:00,GWPH,negative
590902.0,"Zynerba Pharma Shares Up 2.7%; Watch For Stock To React To The Outcome Of Peer GW Pharma's FDA AdCom Meeting, For Which Its Stock Remains Halted",2018-04-19 10:50:00-04:00,GWPH,positive
590903.0,Benzinga Pro's 5 Stocks To Watch Today,2018-04-19 08:25:00-04:00,GWPH,neutral
590904.0,"GW Pharma Shares Halted With Code News Pending, Ahead Of AdCom Panel For Epidiolex",2018-04-19 06:46:00-04:00,GWPH,positive
590905.0,"GW Pharma 6-K Shows FDA AdCom Panel To Take Place Thurs., Apr. 19 Between 8 a.m. To 12:30 p.m. EDT; Nasdaq Halted Shares Ahead Of This Event",2018-04-19 06:13:00-04:00,GWPH,positive
590906.0,"GW Pharma Shares Rallied 11% On Tues., Indicated Up ~2% Premarket Wed. On Light Volume; FDA Tues. Published Briefing Doc For Apr. 19 AdCom Meeting On NDA 210365",2018-04-18 09:15:00-04:00,GWPH,positive
590907.0,32 Biggest Movers From Yesterday,2018-04-18 04:45:00-04:00,GWPH,neutral
590908.0,27 Stocks Moving In Tuesday's Mid-Day Session,2018-04-17 12:51:00-04:00,GWPH,neutral
590909.0,"The Week Ahead: Netflix Earnings, Big Bank Results, FDA Actions Abound",2018-04-16 12:10:00-04:00,GWPH,neutral
590910.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry",2018-04-16 09:46:00-04:00,GWPH,positive
590911.0,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More",2018-04-13 11:38:00-04:00,GWPH,neutral
590912.0,"Florida Rep. Carlos Smith On How His LGBTQ Identity Led Him To Cannabis, Gun Control Advocacy",2018-04-11 15:02:00-04:00,GWPH,negative
590913.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-04-06 17:38:00-04:00,GWPH,positive
590914.0,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,2018-04-03 08:14:00-04:00,GWPH,neutral
590915.0,"Pot Stocks, ETFs And Top News From The Cannabis Industry",2018-04-02 12:57:00-04:00,GWPH,positive
590916.0,"On World Autism Awareness Day, A Look At Biotech Firms With Potential Treatments In The Pipeline",2018-04-02 12:31:00-04:00,GWPH,neutral
590917.0,"Smoking Is Just One Way To Use Marijuana: An Introduction To Vaporizers, Edibles, Oils, Tinctures, Dabs And Other Cannabis Products",2018-03-30 09:37:00-04:00,GWPH,neutral
590918.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-03-23 17:14:00-04:00,GWPH,positive
590919.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-03-16 16:16:00-04:00,GWPH,positive
590920.0,GW Pharma Announces Receipt of Allowances  By USPTO For 5 New Epiciolex Patents,2018-03-13 16:01:00-04:00,GWPH,neutral
590921.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-03-09 16:40:00-05:00,GWPH,positive
590922.0,GW Pharma Shares Spike ~3% Over Last Min. Following Mention Of Unusual Call Activity By Jon Najarian On CNBC,2018-03-07 13:03:00-05:00,GWPH,positive
590923.0,"Pot Stocks, ETFs And Top News From The Cannabis Industry This Week",2018-03-02 15:38:00-05:00,GWPH,positive
590924.0,GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency for Cannabidiol for the Treatment of Tuberous Sclerosis,2018-02-27 07:02:00-05:00,GWPH,neutral
590925.0,"Pot Stocks, ETFs And Top News From The Cannabis Industry This Week",2018-02-25 16:36:00-05:00,GWPH,positive
590926.0,56 Biggest Movers From Yesterday,2018-02-23 05:17:00-05:00,GWPH,neutral
590927.0,"10 Stocks To Watch For February 22, 2018",2018-02-22 05:13:00-05:00,GWPH,neutral
590928.0,7 Stocks Moving In Wednesday's After-Hours Session,2018-02-21 17:09:00-05:00,GWPH,neutral
590929.0,"GW Pharma Reports Prelim. Results From Phase 2a Study Of GWP42006: Says Study Did Not Meet Primary Endpoint, Co. 'remains committed to continued development of GWP42006 for autism spectrum disorders'",2018-02-21 16:22:00-05:00,GWPH,positive
590930.0,"Wonder Women Of Weed: Jodie Emery, The Entrepreneurial Rebel With A Cause",2018-02-20 11:47:00-05:00,GWPH,negative
590931.0,30 Stocks Moving In Tuesday's Pre-Market Session,2018-02-20 08:00:00-05:00,GWPH,neutral
590932.0,"Pot Stocks, ETFs And Top News From The Cannabis Industry This Week",2018-02-16 16:35:00-05:00,GWPH,positive
590933.0,"Former Mexican President Vicente Fox Talks NAFTA, Trump And Regulated Marijuana Trade",2018-02-15 11:15:00-05:00,GWPH,neutral
590934.0,"Pot Stocks, ETFs And Other Top News In The Cannabis Industry This Week",2018-02-09 17:12:00-05:00,GWPH,positive
590935.0,"Leerink Swann Maintains Outperform on GW Pharmaceuticals, Raises Price Target to $157.00",2018-02-06 09:06:00-05:00,GWPH,neutral
590936.0,"GW Pharma Reports Q1 EPS $(2.43) vs $(2.13) Est.,, Sales $7.728M May Not Compare to $2.28M Est.",2018-02-05 16:02:00-05:00,GWPH,neutral
590937.0,GW Pharma Reports EMA Acceptance Of Epidiolex MAA For Review,2018-02-05 16:00:00-05:00,GWPH,positive
590938.0,Pot Stocks & ETFs: Top News In The Cannabis Industry For The Week,2018-02-02 17:17:00-05:00,GWPH,positive
590939.0,Football And Weed: Former NFL Players Weigh In On Why Many Are Getting Involved With CBD Companies,2018-02-02 10:32:00-05:00,GWPH,neutral
590940.0,"Wonder Women Of Weed: Sara Gullickson, The Licensing Advisor Sitting At The Head Of The Boys' Table",2018-02-01 08:02:00-05:00,GWPH,neutral
590941.0,A New Marijuana Stock Index Debuts Today: These Are The 30 Cannabis Companies In It,2018-01-31 09:00:00-05:00,GWPH,neutral
590942.0,Pot Stocks & ETFs: This Week's Top News In The Cannabis Industry,2018-01-26 16:25:00-05:00,GWPH,positive
590943.0,"The Market In 5 Minutes: GDP, Intel's Beat, XFL's Return, Bitcoin And Japan",2018-01-26 09:02:00-05:00,GWPH,neutral
590944.0,Why GW Pharma's Epidiolex Results Could Shape The Future Of Cannabis-Based Therapeutics,2018-01-25 15:51:00-05:00,GWPH,neutral
590945.0,"420 Investor Alan Brochstein Notes While He Sold Out Of His Positions In More Speculative Cannabis Names Following Rescinding Of Cole Memo, He 'kept 5 or 6% exposure to GW Pharma'",2018-01-25 15:44:00-05:00,GWPH,positive
590946.0,420 Investor Alan Brochstein Responds To Publication Of GW Pharma's Epidiolex Study Results In Lancet: 'Results aren't really news. What's actually more relevant is the fact that peer-reviewed medical journals are publishing cannabis-related results.',2018-01-25 15:44:00-05:00,GWPH,neutral
590947.0,"UPDATE: GW Pharma's Schultz Tells Benzinga Regarding Epidiolex: 'The clinical studies that we have run have been robust, well controlled and are hopefully supportive of approvals' In The U.S. and Europe",2018-01-25 15:12:00-05:00,GWPH,positive
590948.0,"GW Pharma VP Stephen Schultz, In Benzinga Interview, Highlights Publication Of Results From Lennox-Gastaut Study In Lancet, NEJM As Validation For 'how important the medical community sees these results as'",2018-01-25 15:12:00-05:00,GWPH,positive
590949.0,"Cannabis Industry Group Announces National Standards, Starts With Marijuana Product Packaging And Labeling",2018-01-24 15:30:00-05:00,GWPH,neutral
590950.0,Pot Stocks & ETFs: This Week's Top News In The Cannabis Industry,2018-01-19 17:29:00-05:00,GWPH,positive
590951.0,"Colorado Cannabis Sales Hit $1.49 Billion In 2017: Taxes Up To $247 Million, Medical Sales Down To $420 Million",2018-01-18 13:16:00-05:00,GWPH,neutral
590952.0,"Wonder Women Of Weed: Yvonne DeLaRosa Green, The Latina Revolutionizing Conscious Commerce With Cannabis",2018-01-18 08:20:00-05:00,GWPH,neutral
590953.0,5 Weed Stocks To Watch In 2018,2018-01-17 13:06:00-05:00,GWPH,neutral
590954.0,Pot Stocks & ETFs: This Week's Top News In The Cannabis Industry,2018-01-13 11:02:00-05:00,GWPH,positive
590955.0,Even Alabama Republicans Disagree With Attorney General Jeff Sessions' Views On Marijuana Legalization,2018-01-11 07:10:00-05:00,GWPH,negative
590956.0,Cannabis Experts Discuss The Silver Lining In Jeff Sessions' Marijuana Policy,2018-01-04 14:24:00-05:00,GWPH,neutral
590957.0,"Editorial VP Of Marijuana Business Daily Chris Walsh On Cannabis Industry Following Sessions Order: 'The industry is very strong, it has a lot of support, and I'm confident it's going to weather the storm'",2018-01-04 14:19:00-05:00,GWPH,positive
590958.0,"420 Investor Alan Brochstein On Who May Benefit From Sessions' Order, 'Eventually, if things play out poorly, it's probably to the benefit of these Canadian [marijuana] stocks'",2018-01-04 14:19:00-05:00,GWPH,positive
590959.0,"420 Investor Alan Brochstein Tells Benzinga, Regarding AG Sessions Marijuana Order, 'I don't think it will necessarily be negative, but it's going to really sap sentiment over the next few days.'",2018-01-04 14:19:00-05:00,GWPH,negative
590960.0,"The 420 Investor Talks Alcohol, Blockchain And Cannabis, Spurns MJX ETF",2018-01-02 17:37:00-05:00,GWPH,neutral
590961.0,"GW Pharma Reports Submitted MAA In Europe For Epidiolex For Treatment Of Leonnx-Gastaut Syndrome, Dravet Syndrome",2017-12-29 07:00:00-05:00,GWPH,neutral
590962.0,A Peek Into The Markets: U.S. Stock Futures Gain Ahead Of Economic Data,2017-12-28 07:51:00-05:00,GWPH,positive
590963.0,GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex,2017-12-28 07:01:00-05:00,GWPH,positive
590964.0,Has The Crypto Craze Killed The Marijuana Investing Buzz?,2017-12-27 17:17:00-05:00,GWPH,negative
590965.0,"Benzinga's Bulls & Bears: Looking Back, Looking Forward",2017-12-24 09:05:00-05:00,GWPH,neutral
590966.0,7 Best Marijuana Stocks That Blazed A Trail In 2017,2017-12-23 10:41:00-05:00,GWPH,positive
590967.0,3 Biotech Pipeline Areas To Keep An Eye On In 2018,2017-12-20 12:37:00-05:00,GWPH,neutral
590968.0,"Asset Class Year In Review: Equities, Commodities, Cryptos, And Cannabis",2017-12-19 07:37:00-05:00,GWPH,positive
590969.0,Goldman Sachs Sees 40% Upside In GW Pharmaceuticals,2017-12-14 11:57:00-05:00,GWPH,neutral
590970.0,"Benzinga's Top Upgrades, Downgrades For December 14, 2017",2017-12-14 08:58:00-05:00,GWPH,positive
590971.0,Goldman Sachs Upgrades GW Pharmaceuticals to Buy,2017-12-14 08:11:00-05:00,GWPH,neutral
590972.0,GW Pharma Does Not Have to Make an Upfront Payment to Otsuka for the Rights to Develop and Commercialize Sativex in the US,2017-12-13 07:04:00-05:00,GWPH,neutral
590973.0,"GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize Sativex in the US, Terms Not Disclosed",2017-12-13 07:04:00-05:00,GWPH,neutral
590974.0,GW Pharmaceuticals Announces Full Exercise Of Underwriter's Option To Purchase 360K Additional ADSs From Previously Announced Offering,2017-12-11 17:23:00-05:00,GWPH,neutral
590975.0,GW Pharmaceuticals Prices 2.4M ADS Offering @$115/ADS,2017-12-07 04:40:00-05:00,GWPH,neutral
590976.0,GW Pharma Reports Proposed Offering Of $225M ADSs,2017-12-05 16:01:00-05:00,GWPH,neutral
590977.0,Zynerba Pharmaceuticals Volatile After Epilepsy Study Results,2017-12-04 12:32:00-05:00,GWPH,neutral
590978.0,"GW Pharmaceuticals Reports FY17 Sales $11M, Loss Of $175.9M",2017-12-04 07:03:00-05:00,GWPH,negative
590979.0,"7 Stocks To Watch For December 4, 2017",2017-12-04 05:03:00-05:00,GWPH,neutral
590980.0,"Earnings Scheduled For December 4, 2017",2017-12-04 04:30:00-05:00,GWPH,neutral
590981.0,"13F Filing From Baker Bros Shows New Stake In GW Pharmaceuticals, Slight Increase To Ignyta Stake, Exited Stake In Palatin Technologies and Zogenix",2017-11-14 16:01:00-05:00,GWPH,positive
590982.0,"Bank of America Maintains Buy on GW Pharmaceuticals Plc - American Depositary Shares, Lowers Price Target to $158.00",2017-11-14 08:47:00-05:00,GWPH,positive
590983.0,GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Completes Rolling New Drug Application Submission to U.S. Food and Drug Administration for Epidiolex,2017-10-30 07:07:00-04:00,GWPH,neutral
590984.0,"Super Bowl Champ Marvin Washington Talks Cannabis-Derived Therapeutics For Athletes, Isodiol's Leadership In CBD",2017-10-29 13:22:00-04:00,GWPH,positive
590985.0,22 Stocks To Watch After President Trump Declares Opioid Epidemic A National Health Emergency,2017-10-26 15:24:00-04:00,GWPH,negative
590986.0,Watch Non-Opioid Pain/Rare Disease Treatment Names Amid Comments From First Lady Trump Related To America's Opioid Crisis,2017-10-26 14:27:00-04:00,GWPH,negative
590987.0,From Military Commander To Cannabis CEO: The Story Of One Of The Fastest-Growing Tech Companies In The Marijuana Industry,2017-10-26 13:04:00-04:00,GWPH,neutral
590988.0,Benzinga's Option Alert Recap From October 23,2017-10-23 16:56:00-04:00,GWPH,positive
590989.0,GW Pharma Option Alert: Jan 19 $130 Calls Above Ask!: 2000 @ $2.0 vs 277 OI; Ref=$106.2,2017-10-23 12:15:00-04:00,GWPH,positive
590990.0,"Making Marijuana Safer: Jessica Versteeg Explains Paragon Coin, The New Cannabis Blockchain",2017-10-19 16:22:00-04:00,GWPH,positive
590991.0,"Investing In Marijuana: Cannabis Industry Raises Hit $1.8 Billion, Up 150% Year Over Year",2017-10-16 08:41:00-04:00,GWPH,neutral
590992.0,How This Leading Marijuana Company Is Capitalizing On The Rise Of Smoke-Free Weed Consumption,2017-10-12 14:15:00-04:00,GWPH,neutral
590993.0,Three Ways To Approach The Cannabis Trade,2017-10-12 12:33:00-04:00,GWPH,neutral
590994.0,5 Tips To Successfully Open And Operate A Marijuana Dispensary,2017-10-08 17:54:00-04:00,GWPH,positive
590995.0,What A Free Marijuana Trade With Mexico Would Look Like: Former President Vicente Fox To Speak In Phoenix Oct. 14,2017-10-06 16:30:00-04:00,GWPH,positive
590996.0,Learn From Parliament's George Clinton And Nat Geo's Jason Silva At This Cannabis Tech Event,2017-10-06 13:15:00-04:00,GWPH,neutral
590997.0,How To Get A Marijuana Dispensary License: Expert Shares Fundamental Tips,2017-10-03 12:40:00-04:00,GWPH,positive
590998.0,What Do Zogenix Drug Study Results Mean For GW Pharmaceuticals' Epidiolex?,2017-10-02 13:36:00-04:00,GWPH,neutral
590999.0,Looking For Jobs In The Marijuana Industry? These Events Might Be A Good Start,2017-09-29 17:56:00-04:00,GWPH,positive
591000.0,Montel Williams' Battle With Multiple Sclerosis And The Miracle Of Medical Marijuana,2017-09-15 12:27:00-04:00,GWPH,positive
591001.0,Green Market Report Debuts With Intentions Of Becoming The 'CNBC Or Dow Jones Of Cannabis',2017-09-14 08:42:00-04:00,GWPH,neutral
591002.0,Front Range Biosciences CEO Explains How Tissue Culture Can Help Marijuana Cultivators Drive Efficiency And Scale,2017-09-12 12:35:00-04:00,GWPH,positive
591003.0,13G/A Filing Shows Scopia Capital Reporting 11.29% Stake In GW Pharmaceuticals,2017-09-11 17:17:00-04:00,GWPH,neutral
591004.0,Nemus Bioscience CEO Talks 'Waves Of Dominance' In The Cannabis Therapeutics Industry,2017-09-05 11:22:00-04:00,GWPH,positive
591005.0,"Jim Cramer Advises His Viewers On Domino's Pizza, Allergan And More",2017-08-31 09:00:00-04:00,GWPH,neutral
591006.0,What's The Difference Between Zynerba and GW Pharma's Epilepsy Drugs?,2017-08-18 09:18:00-04:00,GWPH,neutral
591007.0,Why Industrial Hemp Could Prove A Larger Economic Driver Than Marijuana,2017-08-10 10:28:00-04:00,GWPH,neutral
591008.0,"5 Tips To Start A Successful (And Legal) Marijuana Grow Operation, According To Serge Chistov",2017-08-09 08:17:00-04:00,GWPH,positive
591009.0,Is GW Pharma Now The Future Of Cannabis-Based Drugs?,2017-08-08 10:18:00-04:00,GWPH,neutral
591010.0,"Benzinga's Top Upgrades, Downgrades For August 8, 2017",2017-08-08 09:34:00-04:00,GWPH,positive
591011.0,Maxim Group Downgrades GW Pharmaceuticals Plc - American Depositary Shares to Hold,2017-08-08 07:53:00-04:00,GWPH,positive
591012.0,GW Pharma Says Its Epidiolex NDA Submission Is Underwaqy With Final Sections Expected To Be Completed In October,2017-08-07 16:10:00-04:00,GWPH,neutral
591013.0,"GW Pharmaceutials Reports Q3 EPS $2.07 vs $(1.51) Est., Sales $3.138M vs $2.57M Est.",2017-08-07 16:10:00-04:00,GWPH,neutral
591014.0,Largest Marijuana Dispensary Group In The US Now Takes Debit Payments,2017-08-07 14:13:00-04:00,GWPH,neutral
591015.0,What Zynerba's Flop Means For CBD Therapies And GW Pharmaceuticals,2017-08-07 09:41:00-04:00,GWPH,negative
591016.0,"Alan Brochstein Tells Benzinga Zynerba's Clinical Failure 'Not a CBD failure,' But A Failure Of Transdermal Delivery; Says 'GWPH may fall in sympathy, but this is actually positive news,' Due To Reduced Competition",2017-08-07 09:37:00-04:00,GWPH,positive
591017.0,Marijuana Cultivator DOJA Cannabis To Start Trading On The CSE Wednesday,2017-08-07 08:41:00-04:00,GWPH,neutral
591018.0,"Meet SpringBig, A Leader In Marijuana Marketing That's Getting Dispensaries Into Users' Smartphones",2017-08-04 14:31:00-04:00,GWPH,neutral
591019.0,Guy Adami Is Bullish On GW Pharmaceuticals,2017-08-04 07:22:00-04:00,GWPH,neutral
591020.0,It's High Time For The Cannabis-Related Drug Pipeline,2017-08-03 17:09:00-04:00,GWPH,neutral
591021.0,A Cannabis Wonderland? This Company Bought A Whole Town In California To Create A Marijuana Tourism Destination,2017-08-03 09:25:00-04:00,GWPH,positive
591022.0,"Lightning Round: Jim Cramer Weighs In On GW Pharma, Snap-on, Teekay And More",2017-08-02 07:25:00-04:00,GWPH,neutral
591023.0,This Compostable Cannabis-Infused Coffee Pod Maker Is All About Social Impact,2017-08-01 14:36:00-04:00,GWPH,neutral
591024.0,"Meet Avicanna, The First Marijuana Company To Be Accepted Into Johnson & Johnson Innovation, JLABS @ Toronto",2017-07-25 12:29:00-04:00,GWPH,positive
591025.0,Picking Marijuana-Related Investments: Phyto Partners Walks Us Through Its Criteria,2017-07-23 17:38:00-04:00,GWPH,neutral
591026.0,"Discussing Snoop Dogg's Marijuana-Focused VC Firm: 'Beyond Wearing The Investor Hat, We Differentiate With A Broad Internal Ecosystem'",2017-07-20 14:17:00-04:00,GWPH,neutral
591027.0,Nevada Marijuana Emergency Shows The Real Size Of America's Demand For Cannabis,2017-07-13 14:08:00-04:00,GWPH,negative
591028.0,Lighting It Up: How Marijuana-Focused HERB Developed Engagement Levels Comparable To Vice And Buzzfeed,2017-07-12 17:02:00-04:00,GWPH,positive
591029.0,"How Marijuana Can Help Treat Addictions To Opioids, Other Rx Drugs And Alcohol",2017-07-11 14:57:00-04:00,GWPH,positive
591030.0,Marijuana Venture Capitalist: How To Succeed As Investor And Entrepreneur,2017-07-10 11:16:00-04:00,GWPH,positive
591031.0,Beyond The Marijuana Index: MJIC CEO Talks Company's Desire To Be 'Amazon Of Weed',2017-07-06 13:34:00-04:00,GWPH,positive
591032.0,"Data Show The Typical Medical Marijuana Consumer Is Upscale, Insured And Physician-Diagnosed",2017-07-03 11:56:00-04:00,GWPH,neutral
591033.0,Marijuana Could Help Treat Alzheimer's: Here's How It Would Work,2017-06-29 11:21:00-04:00,GWPH,positive
591034.0,Marijuana Venture Capitalist On CanopyBoulder's Investments: We Focus On Co's That Can Scale To Spectacular Levels Very Quickly,2017-06-27 12:36:00-04:00,GWPH,neutral
591035.0,Consumer Study Shows Which Cannabis Brands Are Winning The Design Race And Why,2017-06-26 15:13:00-04:00,GWPH,positive
591036.0,Meet Tradiv: A Startup Bringing Cannabis Wholesale Into The Digital Age – Before It's Too Late,2017-06-19 08:54:00-04:00,GWPH,neutral
591037.0,Marijuana Industry Insiders On Why The IRS Is Targeting Them — And How To Avoid Business Disruption,2017-06-14 16:37:00-04:00,GWPH,negative
591038.0,"Goldman Sachs Global Healthcare Conference Continues Today, Presenters Include: Agilent, Sage Therapeutics, and GW Pharmaceuticals",2017-06-14 07:58:00-04:00,GWPH,neutral
591039.0,New Frontier Data CEO On Collective Effort Behind Marijuana Legalization: Coming Together Helps The Whole Cannabis Industry,2017-06-13 07:09:00-04:00,GWPH,positive
591040.0,"This Weekend, The SECC Expo Brings Cannabis Education To Florida",2017-06-09 13:47:00-04:00,GWPH,neutral
591041.0,Viridian Discusses The Spicer Effect On Marijuana Stocks: 'It Wasn't The Deathblow Some People Were Afraid Of',2017-06-01 10:10:00-04:00,GWPH,neutral
591042.0,Veteran Affairs Secretary Shulkin Says Medical Marijuana In States Where It's Legal May Have 'Some evidence that this is beginning to be helpful',2017-05-31 12:13:00-04:00,GWPH,positive
591043.0,'Get Lit': Blend's Data Reveals How Millennials Talk About Weed,2017-05-27 19:03:00-04:00,GWPH,neutral
591044.0,The Market In 5 Minutes,2017-05-25 09:00:00-04:00,GWPH,neutral
591045.0,GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Groundbreaking Study of Epidiolex in NEJM,2017-05-25 06:36:00-04:00,GWPH,neutral
591046.0,"GW Pharma Highlights Results From A Phase 3 Study Of Epidiolex Published In New England Journal Of Medicine, Showing Epidiolex Significantly Reduced Monthly Convulsive Seizure Frequency",2017-05-24 17:01:00-04:00,GWPH,neutral
591047.0,'Pot Baron' Andy Williams Discusses Challenges Of Entering The Cannabis Industry And How To Overcome Them,2017-05-22 15:58:00-04:00,GWPH,positive
591048.0,The Government's Best Weapon Against Heroin Might Be Marijuana,2017-05-21 12:38:00-04:00,GWPH,negative
591049.0,Meet MSNBC 'Pot Baron' Andy Williams And His Multiple Marijuana Businesses,2017-05-19 13:36:00-04:00,GWPH,neutral
591050.0,Patent Wars Surprisingly Reach The Cannabis Industry: How Do You Register A Plant?,2017-05-18 11:44:00-04:00,GWPH,negative
591051.0,"Bank Of America Health Care Conference Continues Today; Presenters Include Celgene, Ionis, Neurocrine Biosciences, Cigna, GW Pharma, Allergan, Ironwood Pharma, Tenet Healthcare, Civitas Solutions, & Amgen",2017-05-17 09:03:00-04:00,GWPH,positive
591052.0,How Cannabis And Hyperbarics Connect: Alternative Therapies And Collective Policing,2017-05-15 14:00:00-04:00,GWPH,neutral
591053.0,Jeff The 420 Chef Explains How He Makes Medical Marijuana Edibles That Don't Taste Like Weed,2017-05-14 12:58:00-04:00,GWPH,negative
591054.0,Meet Compassionate Certification Centers: The Company Merging Education And Entrepreneurship In Cannabis,2017-05-12 14:10:00-04:00,GWPH,positive
591055.0,Green Flower Media CEO Explains Why Cannabis Education Is Key To Improving People's Lives,2017-05-11 15:42:00-04:00,GWPH,positive
591056.0,Analyst: GW Pharma Has Started Laying The Groundwork For Taking Epidiolex To Market,2017-05-10 08:53:00-04:00,GWPH,neutral
591057.0,"Sen. Daylin Leach Talks Cannabis Bill 528: Adult Use And Economic, Societal Profit",2017-05-10 08:17:00-04:00,GWPH,positive
591058.0,"GW Pharmaceuticals Reports Q2 EPS $(1.70) vs $(1.46) Est., Sales $2.039M vs $2.62M Est.",2017-05-09 17:05:00-04:00,GWPH,neutral
591059.0,GW Pharmaceuticals Reports Six Months Ended Loss Of $62.6M,2017-05-09 16:14:00-04:00,GWPH,negative
591060.0,"Pennsylvania Sen. Daylin Leach Talks Marijuana Legalization: Prohibition Is A Cruel, Heartless Policy",2017-05-09 10:47:00-04:00,GWPH,negative
591061.0,Cannabis Industry Has Already Raised Over $730 Million In 2017,2017-05-08 09:55:00-04:00,GWPH,neutral
591062.0,Why Hemp Could Be The Future Of Plastics,2017-05-05 11:10:00-04:00,GWPH,neutral
591063.0,Diego Pellicer CEO Talks Building A National Cannabis Brand Under A Trump Administration,2017-05-02 06:49:00-04:00,GWPH,neutral
591064.0,"Weed Vs. Opioids: Nontraditional And Traditional Biotech Take On Wall Street, But Who's Winning?",2017-04-30 12:38:00-04:00,GWPH,positive
591065.0,IAnthus CEO Talks About Raising Capital For U.S. Cannabis Companies In Canadian Markets – And Marijuana Stocks To Watch,2017-04-28 08:44:00-04:00,GWPH,neutral
591066.0,"Cannabis Expert On Marijuana Legalization: Rhode Island, Texas Might Be Next, Vermont Will Have To Wait",2017-04-22 11:43:00-04:00,GWPH,neutral
591067.0,IAnthus CEO On Marijuana Legalization In U.S. And Canada: A Good Model Makes The Decision Easier,2017-04-21 09:56:00-04:00,GWPH,positive
591068.0,The 420 Investor Breaks Down The Marijuana Sector,2017-04-20 16:39:00-04:00,GWPH,neutral
591069.0,2 New Ways To Invest In Marijuana Stocks: Cannabis ETFs,2017-04-20 12:24:00-04:00,GWPH,neutral
591070.0,"From NCAA Outlaw To Medical Marijuana Entrepreneur: Treyous Jarrells Talks Opioids, Weed And Changing The Stigma",2017-04-20 09:53:00-04:00,GWPH,neutral
591071.0,"Gw Pharma Issues Release Highlighting Subsidiary Greenwich Biosciences Released New Data on Epidiolex Showing 'adding Epidiolex to patients' current treatment significantly reduced the frequency of drop seizures at both 10 mg/kg/day, 20mg/kg/day doses'",2017-04-19 10:32:00-04:00,GWPH,negative
591072.0,GW pharmaceuticals Highlights Positive Results From Second Phase 3 Study Of Epidiolex With American Academy Of Neurology,2017-04-18 16:27:00-04:00,GWPH,positive
591073.0,"GreenWave's Matt Karnes Talks About Cannabis Banking, Tax Burdens And Stocks To Watch",2017-04-18 08:49:00-04:00,GWPH,negative
591074.0,GreenWave's Matt Karnes Predicts Fully Legal Cannabis Markets In 8 New States By 2018,2017-04-17 14:21:00-04:00,GWPH,positive
591075.0,Industry Insider On Marijuana Legalization In Texas: Cannabis Reform Might Come Sooner Than People Think,2017-04-04 14:30:00-04:00,GWPH,neutral
591076.0,"Meet One Of The Largest VC-Backed Cannabis Companies In The U.S., Generating 300% ROI In 10 Weeks",2017-04-03 15:41:00-04:00,GWPH,neutral
591077.0,GW Pharma Reports Epidiolex Received Orphan Drug Designation from EMA for Treatment of Lennox-Gastaut Syndrome,2017-03-29 07:02:00-04:00,GWPH,neutral
591078.0,"Rapper 'The Game' Talks About His Cannabis Venture: 'Setting The Standard For Quality Medicine, Patient Care'",2017-03-28 15:00:00-04:00,GWPH,positive
591079.0,'Trump Schmump': H.C. Wainwright Raises Zynerba's Target To $30,2017-03-28 09:25:00-04:00,GWPH,neutral
591080.0,ArcView's Troy Dayton Explains Why The Cannabis Industry Will Thrive Even If Trump Cracks Down On Marijuana,2017-03-27 15:27:00-04:00,GWPH,neutral
591081.0,Cronos Execs On Marijuana Legalization In Canada And How It Affects The Co: Market Could Be Ready To Go By 2019,2017-03-21 13:40:00-04:00,GWPH,positive
591082.0,Cronos Group Execs Discuss The Challenges Of Exporting Cannabis As An Insurance-Reimbursed Product,2017-03-19 22:11:00-04:00,GWPH,positive
591083.0,Marijuana Stocks And Indices On A Downtrend: Who's Taking The Heat And Why,2017-03-19 14:17:00-04:00,GWPH,neutral
591084.0,Garbage Companies & The Marijuana Industry: Expert Warns About Overvalued Cannabis Stocks,2017-03-17 10:36:00-04:00,GWPH,negative
591085.0,Why Education Could Be The Biggest Beneficiary Of Cannabis Legalization,2017-03-16 08:56:00-04:00,GWPH,positive
591086.0,Getting Into The Business Of Medical Marijuana: An Interview With IGC CEO Ram Mukunda,2017-03-15 07:47:00-04:00,GWPH,neutral
591087.0,"Trump, Sessions, Spicer And Medical Marijuana: Industry Insiders Discuss The Future Of Cannabis",2017-03-14 10:40:00-04:00,GWPH,neutral
591088.0,Marijuana Stocks: How CEOs Can Navigate Market Volatility (And Survive Spicer And Sessions),2017-03-10 08:39:00-05:00,GWPH,neutral
591089.0,Emerging Cannabis Industry Presents Big Opportunities For Investors,2017-03-08 16:08:00-05:00,GWPH,positive
591090.0,"Cowen Annual Healthcare Conference Concludes Today; Presenters Include Agilent Tech, Incyte, GW Pharma, Teva Pharma, NantKwest, Seattle Genetics, And Celgene",2017-03-08 08:25:00-05:00,GWPH,neutral
591091.0,GW Pharmaceuticals Names Scott Giacobello as CFO,2017-03-07 05:01:00-05:00,GWPH,neutral
591092.0,Mentor Capital Acquires $1M Shares Of GW Pharmaceuticals,2017-03-03 11:18:00-05:00,GWPH,positive
591093.0,Washington Post Says Politician Introduces Bill To End 'Federal War on Marijuana',2017-03-02 10:08:00-05:00,GWPH,negative
591094.0,"Marijuana Stocks Are Having A Great 2017, Despite Sean Spicer's Comments",2017-02-24 18:14:00-05:00,GWPH,positive
591095.0,Up In Smoke? DoJ Will 'Take Action' Against States That Have Legalized Marijuana,2017-02-24 09:58:00-05:00,GWPH,neutral
591096.0,UPDATE: Brochstein Says 'I would argue a medical-only industry will still be a large and growing industry.',2017-02-23 17:11:00-05:00,GWPH,negative
591097.0,"Marijuana Industry Expert, Alan Brochstein, Responds to Spicer Comments on Marijuana: 'There was absolutely no suggestion of any pending actions, but clearly there is a risk the federal gov't walks away from the hands-off approach'",2017-02-23 17:10:00-05:00,GWPH,neutral
591098.0,GW Pharma's Steve Schultz Tells Benzinga Spicer's Comments On DOJ Taking Action On States That Have Legalized Recreational Marijuana 'Will Not Affect' The Company 'At All',2017-02-23 16:10:00-05:00,GWPH,neutral
591099.0,"U.S. Press Secretary Says Can't Comment on If DoJ Will Be 'Taking Action' Against States That Have Legalized Recreational Marijuana, But White House Sees Greater Federal Enforcement of Laws Against Recreational Use",2017-02-23 15:51:00-05:00,GWPH,positive
591100.0,Marijuana Stocks Go On Reversal Mode After 8 Weeks Of Gains: Cannabis Index Down From 52-Week High,2017-02-16 15:37:00-05:00,GWPH,positive
591101.0,Couldn't Make It To Leerink's Global Healthcare Conference? Here Are The Highlights From Day One,2017-02-16 10:43:00-05:00,GWPH,neutral
591102.0,"Leerink Partners Global Healthcare Conference Began Today; Presenters Include Mannkind, Universal Health Services, Celgene, Inogen, Endologix, Biogen, GW Pharma, Regulus, Fate Therapeutics, Puma Biotech, Allergan, Bristol Myers And Synergy Pharma",2017-02-15 10:29:00-05:00,GWPH,neutral
591103.0,Key Presenters At Leerink's Healthcare Conference,2017-02-13 15:52:00-05:00,GWPH,neutral
591104.0,Marijuana Continues To Outperform The Market: Cannabis Stock Index Up For 8th Consecutive Week,2017-02-12 15:06:00-05:00,GWPH,neutral
591105.0,Analyst: GW Pharma's GBM Was Validated,2017-02-07 10:52:00-05:00,GWPH,positive
591106.0,GW Pharma Takes A Step Toward Diversifying,2017-02-07 09:28:00-05:00,GWPH,neutral
591107.0,"Alan Brochstein On GW Pharma Earnings Says 'Positively, the P2 results for glioma are a step towards diversifying the company'",2017-02-07 08:51:00-05:00,GWPH,neutral
591108.0,"Marijuana Industry Expert Alan Brochstein On GW Pharma's Earnings Tells Benzinga :NDA filing for Epidiolex Seems To Have Been Pushed Back Slightly, Co. Now Saying ""Mid 2017"" Instead Of H1, ""Mid"" Could Mean A Bit Later Than June 30th",2017-02-07 08:50:00-05:00,GWPH,neutral
591109.0,Adam Feuerstein  @adamfeuerstein Tweet: $GWPH — Link to GBM study —> clinicaltrials.gov/ct2/show/NCT01… PFS listed as 2ndry endpt ahead of OS but not disclosed.,2017-02-07 07:37:00-05:00,GWPH,neutral
591110.0,Adam Feuerstein Tweets: $GWPH — Link to GBM study —> clinicaltrials.gov/ct2/show/NCT01… PFS listed as 2ndry endpt ahead of OS but not disclosed.,2017-02-07 07:37:00-05:00,GWPH,neutral
591111.0,"GW Pharma Says Epidiolex NDA Submission, Launch Preparation On Track; Highlights New Positive Phase 2 Glioma Data Further Demonstrates Value of Cannabinoid Pipeline",2017-02-07 07:07:00-05:00,GWPH,positive
591112.0,"GW Pharma Reports Q1 Earnings $(0.768)/ADS, Sales $2.538M",2017-02-07 07:06:00-05:00,GWPH,neutral
591113.0,Investing In Marijuana Stocks 2017: Last Week Was The Best So Far,2017-02-03 08:27:00-05:00,GWPH,positive
591114.0,"Canopy Growth, The Largest Marijuana Business In The World, Debuted On Toronto Stock Exchange",2017-02-02 16:03:00-05:00,GWPH,positive
591115.0,"Marijuana Stocks Having A Great 2017: Expert Explains What's Going On Sector By Sector, Week By Week",2017-01-31 09:14:00-05:00,GWPH,positive
591116.0,When Will Canada Legalize Weed? Experts Weigh In,2017-01-24 10:43:00-05:00,GWPH,neutral
591117.0,Cannabis Industry Expert Jay Czarkowski On The Challenges Of Marijuana Legalization And Business Compliance,2017-01-20 12:40:00-05:00,GWPH,positive
591118.0,Viridian Looks Back On 2016: Why The Marijuana Stock Index Gained 236.1%,2017-01-19 10:43:00-05:00,GWPH,positive
591119.0,"Cannabis Industry's $1.2 Billion Investments: Viridian Looks Back On 2016's Marijuana Deals, M&A",2017-01-18 11:11:00-05:00,GWPH,neutral
591120.0,17 For 2017: Top Cannabis Industry Experts Share Predictions For Marijuana - Part 3,2017-01-12 08:52:00-05:00,GWPH,positive
591121.0,"Marijuana Roundup: Jeff Sessions Remains A Wild Card, 68% Of Cops Support Legalization",2017-01-11 16:42:00-05:00,GWPH,positive
591122.0,17 Predictions For Marijuana Markets In 2017 From The Experts - Part 2,2017-01-11 08:42:00-05:00,GWPH,neutral
591123.0,Top Cannabis Industry Experts Share 17 Predictions For Marijuana Markets In 2017 - Part 1,2017-01-10 08:21:00-05:00,GWPH,positive
591124.0,5 Overvalued Cannabis Stocks - Part 3: People Price Marijuana Stocks Like Lottery Tickets,2017-01-09 09:02:00-05:00,GWPH,positive
591125.0,5 Overvalued Cannabis Stocks - Part 2: Funky Capital Structures In The Marijuana Industry,2017-01-06 10:51:00-05:00,GWPH,negative
591126.0,5 Overvalued Cannabis Stocks - Part 1: New Investors Seem To Go For Flashy Names,2017-01-05 12:20:00-05:00,GWPH,neutral
591127.0,"Expert: Lack Of Catalysts, Hurdles Could Spell Trouble For Marijuana Stocks",2017-01-02 10:30:00-05:00,GWPH,negative
591128.0,Keep An Eye On These Canadian Marijuana Stocks In 2017,2016-12-29 15:59:00-05:00,GWPH,neutral
591129.0,Why The Canadian Marijuana Market Is Blooming Amid Uncertainty In The U.S.,2016-12-29 15:59:00-05:00,GWPH,negative
591130.0,Viridian's President On Cannabis Stocks: All Marijuana-Related Sectors Are Spiking As Investors Buy On Weakness,2016-12-27 10:46:00-05:00,GWPH,negative
591131.0,"Viridian's President Shares An Update On Marijuana Stocks, M&A And Investments: Deals Surpass $1 Billion",2016-12-22 14:58:00-05:00,GWPH,positive
591132.0,Budding Opportunity: One Analyst Is Modeling For Zynerba Shares To Double Over The Next Year,2016-12-22 08:27:00-05:00,GWPH,positive
591133.0,"International Law Expert On Cannabis And Banking Under Trump: There's Risk, But To A Certain Degree",2016-12-21 08:35:00-05:00,GWPH,positive
591134.0,International Law Expert On Support For Marijuana Legalization: 'Common Sense Is Prevailing',2016-12-20 09:01:00-05:00,GWPH,positive
591135.0,International Law Expert Explains Tax Implications And The Search For Legitimacy In Cannabis Industry,2016-12-19 10:09:00-05:00,GWPH,neutral
591136.0,Marijuana Industry: Viridian's President Explains Why He's Concerned About The Vape Sector,2016-12-18 20:53:00-05:00,GWPH,neutral
591137.0,The Risks Of The Trade: Providing Accounting Services For The Marijuana Industry,2016-12-17 20:14:00-05:00,GWPH,negative
591138.0,"Viridian Experts Talk Recent Cannabis Industry Deals: M&A, Capital Raises And IPOs",2016-12-16 08:52:00-05:00,GWPH,neutral
591139.0,Viridian Shares A Look At Its Cannabis Stock Index And Potential Marijuana ETF,2016-12-15 06:45:00-05:00,GWPH,positive
591140.0,Viridian's President On Cannabis-Related Opportunities: AgTech And BioTech Offer Value To Investors,2016-12-14 10:56:00-05:00,GWPH,positive
591141.0,"'Cannabis Brings People Together': Blues Traveler Drummer Talks About Sharing A Joint With Metallica, Neil Young, Marilyn Manson",2016-12-13 17:06:00-05:00,GWPH,positive
591142.0,Reads For The Weed-Kend: Marijuana Industry Experts Remain Optimistic Heading Into A Trump Administration,2016-12-10 20:57:00-05:00,GWPH,positive
591143.0,Jim Cramer Shares His Thoughts On Nordic American Tanker And GW Pharmaceuticals,2016-12-09 08:16:00-05:00,GWPH,positive
591144.0,GW Pharma's Price Target Raised To $208 At Cantor,2016-12-05 14:24:00-05:00,GWPH,neutral
591145.0,GW Pharma Ending The Year On A High Note,2016-12-05 11:48:00-05:00,GWPH,neutral
591146.0,The Technical Take: GW Pharmaceuticals Higher After Q4 Report,2016-12-05 10:13:00-05:00,GWPH,neutral
591147.0,GW Pharma Impresses Analysts With Phase 3 Trial Data,2016-12-05 08:07:00-05:00,GWPH,positive
591148.0,"GW Pharma Q4 EPS $(0.07) vs $(1.58) Est, Revenue $2.16M vs $3.60M Est, May Not Compare",2016-12-05 07:01:00-05:00,GWPH,neutral
591149.0,"Must Watch Stocks for December 5, 2016",2016-12-05 04:42:00-05:00,GWPH,neutral
591150.0,"Earnings Scheduled For December 5, 2016",2016-12-05 04:16:00-05:00,GWPH,neutral
591151.0,"American Epilepsy Society Meeting Begins Today, Day 1 Of 5",2016-12-02 08:37:00-05:00,GWPH,neutral
591152.0,"ArcView CEO Troy Dayton On Cannabis Going Mainstream, Entering Major Capital Markets",2016-11-30 13:49:00-05:00,GWPH,neutral
591153.0,ArcView CEO Troy Dayton Shares Optimistic Outlook For The Marijuana Industry Under Trump,2016-11-29 14:52:00-05:00,GWPH,positive
591154.0,ArcView CEO Troy Dayton Talks About The Company And The Collective Effort Behind Marijuana Legalization,2016-11-28 16:11:00-05:00,GWPH,neutral
591155.0,5 BioPharma Catalysts Expected Around Christmas,2016-11-27 08:56:00-05:00,GWPH,neutral
591156.0,Chris Christie Calls Marijuana Revenue 'Blood Money',2016-11-23 12:25:00-05:00,GWPH,neutral
591157.0,Concerns Over GW Pharma's Epilepsy Drug-On-Drug Interactions Might Be Overblown,2016-11-23 12:12:00-05:00,GWPH,neutral
591158.0,"GW Pharma VP Responds Following Abstract Results Monday, Tells Benzinga Drug-Drug Interactions Are Commonplace, No Adverse Reaction Or Efficacy Issues Have Been Observed In Epidiolex Studies Where Drug Interactions Occurred",2016-11-23 11:28:00-05:00,GWPH,negative
591159.0,"Marijuana-Related Stock Makes It To The NYSE, While Dispensaries Prepare For The Thanksgiving Spike",2016-11-23 09:05:00-05:00,GWPH,neutral
591160.0,"GW Pharma Shares Dip to Session Low at $114.68, Quickly Rebound; Hearing Abstract Results Out, Some Suggesting Abstract Confirms Concerns Related to Drug Interaction",2016-11-21 14:03:00-05:00,GWPH,neutral
591161.0,GW Pharma Sells off to Low of $115.35 on Volume,2016-11-21 14:01:00-05:00,GWPH,negative
591162.0,What To Expect From GW Pharma's Upcoming Round Of Presentations,2016-11-21 09:42:00-05:00,GWPH,neutral
591163.0,GW Pharma To Release Abstracts From Its Presentation At December's American Epilepsy Society Mtg Today,2016-11-21 08:06:00-05:00,GWPH,neutral
591164.0,"Hearing Goldman Issuing Positive Mid-Day Comments on GW Pharma, Highlighting Abstracts Due Out Monday",2016-11-18 15:00:00-05:00,GWPH,positive
591165.0,GW Pharmaceuticals Plc Lower,2016-11-18 10:37:00-05:00,GWPH,negative
591166.0,"Jim Cramer Gives His Opinion On Opko Health, Edwards Lifesciences And GW Pharma",2016-11-15 06:44:00-05:00,GWPH,neutral
591167.0,Marijuana Legalization And A Republican Government: What Does It Mean For The Pot Industry?,2016-11-11 16:24:00-05:00,GWPH,neutral
591168.0,2 Big Medical Marijuana Stocks Riding High Post-Election,2016-11-10 10:45:00-05:00,GWPH,neutral
591169.0,"Marijuana Wins Big On Election Night, But Marijuana Stocks Lose",2016-11-09 13:23:00-05:00,GWPH,negative
591170.0,Election2016: California Votes To Legalize Recreational Marijuana,2016-11-08 23:18:00-05:00,GWPH,neutral
591171.0,Election2016: Florida Medical Marijuana Ballot Initiative Passes,2016-11-08 20:24:00-05:00,GWPH,neutral
591172.0,Reads For The Weed-Kend: Innovative Business Verticals In The Marijuana Industry,2016-10-29 09:43:00-04:00,GWPH,positive
591173.0,Marijuana Expert: 'We're In The Middle Of The Second Boom',2016-10-28 07:31:00-04:00,GWPH,neutral
591174.0,It's High Times For Marijuana Stocks Ahead Of Clinton White House,2016-10-26 09:45:00-04:00,GWPH,neutral
591175.0,GW Pharma Continues To Move On Takeover Speculation,2016-10-20 15:49:00-04:00,GWPH,neutral
591176.0,"GW Pharma Spokesperson Tells Benzinga, 'No comment' Regarding Earlier Chatter Of A Possible Takeover",2016-10-20 11:19:00-04:00,GWPH,negative
591177.0,"GW Pharma Shares Bounce Off Session Lows, Up ~4% Over Last Few Mins as Traders Discussing Unconfirmed Takeover Chatter",2016-10-20 10:04:00-04:00,GWPH,neutral
591178.0,"GW Pharma Set To Fly High: Goldman Sachs Starts Coverage At Buy, Sees 42% Upside",2016-10-07 09:20:00-04:00,GWPH,neutral
591179.0,The Market In 5 Minutes: Unemployment Rate A Tick Higher,2016-10-07 09:05:00-04:00,GWPH,negative
591180.0,18 Stocks Moving In Friday's Pre-Market Session,2016-10-07 08:29:00-04:00,GWPH,neutral
591181.0,"GW Pharmaceuticals +4.3% Premarket @$138.90; Goldman Sachs Initiated With Buy, $189PT",2016-10-07 06:02:00-04:00,GWPH,neutral
591182.0,Leerink Rates Zogenix Outperform Ahead Of AES Meeting,2016-10-04 12:17:00-04:00,GWPH,neutral
591183.0,GW Pharma Rapidly Approaching CNS Launch; Leerink Starts Coverage With $162 Target,2016-10-04 11:14:00-04:00,GWPH,neutral
591184.0,Leerink Swann Assumes GW Pharmaceuticals at Outperform,2016-10-04 06:29:00-04:00,GWPH,neutral
591185.0,Watch These 7 Huge Call Purchases In Friday Trade,2016-09-30 02:22:00-04:00,GWPH,positive
591186.0,Option Alert: GWPH Nov16 150 Calls: 950 @  ASK  $3.40: 1020 traded vs 245 OI: $130.57 Ref,2016-09-29 14:59:00-04:00,GWPH,positive
591187.0,Upside in GW Pharma Shares Intensifies as Near-Term Resistance Level at $126.50 Breached to the Upside; Stock Up 2.3% for Session,2016-09-28 13:33:00-04:00,GWPH,positive
591188.0,Pot Stock Watch: Why Is Zynerba Viewed As A Sympathy Play With GW Pharma?,2016-09-27 16:32:00-04:00,GWPH,positive
591189.0,"Exclusive: GW Pharmaceuticals Talks Epidiolex, Raising Capital & Growing Its Sales Force",2016-09-27 11:15:00-04:00,GWPH,positive
591190.0,"GW Pharma Spokesperson Responds to Benzinga Inquiry on Size of Rare Pediatric Epilepsy Market: 'Latest estimates are more than 30,000 patients with LGS in the US and about 16,000 people with Dravet Syndrome.'",2016-09-27 10:24:00-04:00,GWPH,neutral
591191.0,"GW Pharma Spokesperson Responds to Benzinga Inquiry on Possible Sales Partnership for Epidiolex: 'We are growing our U.S. team rapidly, which will include a sales force.'",2016-09-27 10:24:00-04:00,GWPH,positive
591192.0,Monday Market Wrap: Stocks Fall Nearly 1% To Start Week,2016-09-26 17:01:00-04:00,GWPH,neutral
591193.0,12 Biggest Mid-Day Gainers For Monday,2016-09-26 12:10:00-04:00,GWPH,neutral
591194.0,"Bio Therapeutic Stocks Strong Today Amid News Out of Array, Lipocine, GW Pharma, Aldeyra: Summit Up 15%, Cerulean 10.5%, Clearside 10%, Aviragen 7.2%, Gemphire, Forward Pharma  5%",2016-09-26 11:46:00-04:00,GWPH,positive
591195.0,GW Pharma's Epidiloex Data Is Good News For Zynerba,2016-09-26 11:20:00-04:00,GWPH,positive
591196.0,Benzinga's Volume Movers,2016-09-26 10:42:00-04:00,GWPH,neutral
591197.0,Cantor Raises GW Pharma's Target To $182 Following Second Successful Phase 3 Trial,2016-09-26 10:29:00-04:00,GWPH,positive
591198.0,Stocks Hitting 52-Week Highs,2016-09-26 10:20:00-04:00,GWPH,neutral
591199.0,"Cantor Fitzgerald Maintains Buy on GW Pharmaceuticals, Raises PT to $182.00",2016-09-26 09:44:00-04:00,GWPH,neutral
591200.0,Why This Epidiolex Trial Was Different,2016-09-26 09:21:00-04:00,GWPH,neutral
591201.0,"The Market In 5 Minutes: Oil, Debates And Epidiolex",2016-09-26 09:04:00-04:00,GWPH,neutral
591202.0,15 Stocks Moving In Monday's Pre-Market Session,2016-09-26 08:30:00-04:00,GWPH,neutral
591203.0,A Peek Into The Markets: U.S. Stock Futures Signal Lower Start On Wall Street,2016-09-26 07:50:00-04:00,GWPH,negative
591204.0,GW Pharma's Epidiolex Hits Phase 3 Primary Endpoint For Treating Lennox-Gastaut Syndrome,2016-09-26 07:42:00-04:00,GWPH,neutral
591205.0,Can You Guess This Chart?,2016-09-26 07:29:00-04:00,GWPH,neutral
591206.0,GW Pharmaceuticals Shares Spike to High of $118.20 on Announcement of Second Positive Phase 3 Pivotal Trial For Epidiolex In The Treatment Of Lennox-Gastaut Syndrome,2016-09-26 06:59:00-04:00,GWPH,positive
591208.0,BZ NOTE: Recent Strength In GW Pharma Being Attributed To Rumor Of Morgan Stanley Placing Stock on Restricted List,2016-09-15 12:22:00-04:00,GWPH,positive
591209.0,GW Pharmaceuticals Spikes to High of $101.76 on Volume,2016-09-12 15:06:00-04:00,GWPH,neutral
591210.0,Benzinga's Weekend M&A Chatter,2016-09-11 20:09:00-04:00,GWPH,neutral
591211.0,"Reads For The Weed-Kend: Marijuana Roadside Testing, Pregnancy And Depression",2016-09-11 17:09:00-04:00,GWPH,negative
591212.0,12 Stocks Moving In Friday's Pre-Market Session,2016-09-09 08:29:00-04:00,GWPH,neutral
591213.0,GW Pharmaceuticals -6.5% Premarket @$98; Co Spokesperson Says Morgan Stanley has been Advisor for Many Years,2016-09-09 07:27:00-04:00,GWPH,neutral
591214.0,GW Pharmaceuticals Spikes to High of $105.24,2016-09-08 11:29:00-04:00,GWPH,neutral
591215.0,Technical Alert: GW Pharmaceuticals Holding Most Of Wednesday's Huge Gains,2016-09-08 11:18:00-04:00,GWPH,positive
591216.0,GW Pharmaceuticals Takeover Talk 'Seems A Bit Premature',2016-09-08 09:23:00-04:00,GWPH,neutral
591217.0,The Market In 5 Minutes: iPhone 7 Arrives,2016-09-08 09:08:00-04:00,GWPH,neutral
591218.0,GW Pharmaceuticals -5.7% Premarket @$98.67; Reuters Reported Wednesday Hiring of Morgan Stanley Following Takeover Approaches,2016-09-08 04:45:00-04:00,GWPH,neutral
591219.0,"Benzinga's M&A Chatter for Wednesday September 7, 2016",2016-09-07 19:28:00-04:00,GWPH,neutral
591220.0,iShares NASDAQ Biotech ETF Up 0.5% for Session Following Reuters Report GW Pharma Hired Investment Bankers to Field Approaches,2016-09-07 14:55:00-04:00,GWPH,neutral
591221.0,"UPDATE: GW Pharma Shares Now Up ~19%, Touched Session High at $100.15",2016-09-07 14:51:00-04:00,GWPH,positive
591222.0,"GW Pharma Shares Resume Trade, Continue Higher, Now Up ~15%",2016-09-07 14:50:00-04:00,GWPH,positive
591223.0,GW Pharma Shares to Resume Trade at 2:50:31 p.m. EDT,2016-09-07 14:47:00-04:00,GWPH,positive
591224.0,Hearing GW Pharma Hired Investment Bank Following Approaches,2016-09-07 14:46:00-04:00,GWPH,neutral
591225.0,UPDATE: GW Pharma Shares Now Up 11% for Session,2016-09-07 14:46:00-04:00,GWPH,positive
591226.0,GW Pharma Shares Halted on Circuit Breaker,2016-09-07 14:45:00-04:00,GWPH,positive
591227.0,"Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids",2016-09-06 10:26:00-04:00,GWPH,neutral
591228.0,10 Conditions That Could Soon Be Treated With Cannabis: From Menstrual Cramps To Autism,2016-09-02 10:11:00-04:00,GWPH,neutral
591229.0,Harvard Explains The Health Effects Of Medical And Recreational Use Of Marijuana,2016-08-21 20:02:00-04:00,GWPH,neutral
591230.0,Is GW Pharma's Technical Picture Breaking Down?,2016-08-11 12:34:00-04:00,GWPH,neutral
591232.0,"GW Pharmaceuticals Reports Q3 EPS $(0.23), Rev. $11.49M",2016-08-09 07:19:00-04:00,GWPH,neutral
591233.0,22nd Century Group Alleviates Near-Term Financing Risk After Raising $5 Million In Capital,2016-07-26 13:03:00-04:00,GWPH,negative
591234.0,The Marijuana Industry Is Growing Like Weeds,2016-07-22 16:38:00-04:00,GWPH,positive
591235.0,Why Big Pharma May Push Back Against Legal Marijuana,2016-07-14 08:32:00-04:00,GWPH,positive
591236.0,10 Biggest Mid-Day Losers For Wednesday,2016-07-13 13:09:00-04:00,GWPH,negative
591237.0,12 Stocks Moving In Wednesday's Pre-Market Session,2016-07-13 08:23:00-04:00,GWPH,neutral
591238.0,Filing from GW Pharma Shows Registration for 2.8M Offering at $90/ADS,2016-07-13 06:12:00-04:00,GWPH,neutral
591239.0,GW Pharmaceuticals Reports Proposed Offering Of $150M ADSs,2016-07-12 16:01:00-04:00,GWPH,neutral
591240.0,"Vetr Crowd Bearish On GW Pharma, But Upgrades To 3-Star Rating",2016-07-01 13:57:00-04:00,GWPH,neutral
591241.0,GW Pharma Shares Ticking Higher; Traders Attributing to Vague Positive Chatter,2016-06-28 10:14:00-04:00,GWPH,positive
591242.0,5 Largest Price Target Changes For  Tuesday,2016-06-28 09:26:00-04:00,GWPH,neutral
591243.0,Morgan Stanley Sees 70% Upside In GW Pharma,2016-06-28 08:26:00-04:00,GWPH,neutral
591244.0,GW Pharma CEO Currently on CNBC Following Epidiolex Results,2016-06-27 13:25:00-04:00,GWPH,neutral
591245.0,9 Biggest Mid-Day Gainers For Monday,2016-06-27 12:33:00-04:00,GWPH,neutral
591246.0,GW Pharmaceuticals Surrenders Big Pre-Market Gains,2016-06-27 11:34:00-04:00,GWPH,positive
591247.0,Benzinga's Volume Movers,2016-06-27 11:04:00-04:00,GWPH,neutral
591248.0,Benzinga's Top Initiations,2016-06-27 09:29:00-04:00,GWPH,positive
591249.0,Janney Initiates GW Pharma at Sell,2016-06-27 08:31:00-04:00,GWPH,neutral
591250.0,15 Stocks Moving In Monday's Pre-Market Session,2016-06-27 08:20:00-04:00,GWPH,neutral
591251.0,Investors Light Up GW Pharma After Epidiolex Meets Primary Endpoint; Stock Crosses $100,2016-06-27 08:06:00-04:00,GWPH,neutral
591253.0,GW Pharma Announces Epidiolex Met Primary Endpoint in Phase 3 Trial,2016-06-27 07:03:00-04:00,GWPH,neutral
591254.0,Marijuana Ruling: Is The DEA Re-Scheduling Bullish For Weed Stocks?,2016-06-23 13:31:00-04:00,GWPH,neutral
591255.0,GW Pharma Reports New Planned Development Program in IS for Epidiolex,2016-06-21 07:00:00-04:00,GWPH,neutral
591256.0,Friday's Top Pre-Market Movers,2016-06-03 09:43:00-04:00,GWPH,positive
591257.0,"The Market In 5 Minutes: US Added Just 38,000 Jobs Last Month",2016-06-03 08:56:00-04:00,GWPH,neutral
591258.0,12 Stocks Moving In Friday's Pre-Market Session,2016-06-03 08:18:00-04:00,GWPH,neutral
591259.0,GW Pharma +3.82% Premarket at $96.98; Cantor Initiated GWPH at Buy With $181 PT on Tuesday,2016-06-03 07:28:00-04:00,GWPH,neutral
591260.0,"Cantor Fitzgerald Starts GW Pharmaceuticals At Buy, Positive On Potential For Epidiolex",2016-06-02 17:31:00-04:00,GWPH,positive
591261.0,"Cantor Fitzgerald Initiates Coverage on GW Pharmaceuticals at Buy, Announces $181.00 PT",2016-06-02 16:19:00-04:00,GWPH,neutral
591262.0,GW Pharmaceuticals Lower In Volatile Session,2016-05-31 14:42:00-04:00,GWPH,negative
591263.0,Option Alert: GWPH Jul16 85.0 Puts Sweep: 1150 @  ASK  $6.90: 1150 traded vs 606 OI: $94.39 Ref,2016-05-31 12:33:00-04:00,GWPH,positive
591264.0,"GW Pharma Selling Off, Seeing Action In July 85 Puts",2016-05-31 12:33:00-04:00,GWPH,neutral
591265.0,"GW Pharma Reports Q2 EPS $(0.092), Sales $3.805M",2016-05-05 07:51:00-04:00,GWPH,neutral
591266.0,GW Pharma Sells off to Low of $79.10; May be Attributed to Seeking Alpha Post,2016-04-29 11:20:00-04:00,GWPH,negative
591267.0,"GW Pharmaceuticals Gets Orphan Drug Status For Cannabidiol, Stock Rises",2016-04-21 09:58:00-04:00,GWPH,neutral
591268.0,GW Pharmaceuticals Receives Orphan Drug Designation from FDA for Cannabidiol for Treatment of Tuberous Sclerosis Complex,2016-04-21 07:06:00-04:00,GWPH,neutral
591269.0,Why You Should Be Excited About GW Pharma,2016-04-20 17:07:00-04:00,GWPH,positive
591270.0,4/20 Is Here: These Are The 15 Most Traded Weed Stocks,2016-04-20 08:13:00-04:00,GWPH,neutral
591271.0,6 Weed Stocks That Aren't Penny Stocks,2016-04-19 14:08:00-04:00,GWPH,neutral
591272.0,GW Pharma Reports Initiation of Phase 3 Pivotal Study in Tuberous Sclerosis Complex,2016-04-11 07:08:00-04:00,GWPH,neutral
591273.0,66% Of Vetr Top Raters Bullish On GW Pharma,2016-04-07 15:15:00-04:00,GWPH,positive
591274.0,VEGA Group Issues Short Report On GW Pharma; Expert Calls Thesis 'Flawed',2016-03-28 11:26:00-04:00,GWPH,neutral
591275.0,GW Pharma Off Lows @$77.69; Traders Attributing Weakness to Short Seller Report,2016-03-28 10:12:00-04:00,GWPH,negative
591276.0,UPDATE: Brochstein on Apparent Details of Syntec's Expected Short Report on GW Pharma: 'Not the Case at All' Co. Will Compete Against Non-FDA Approved Manufacturers of CBD Products,2016-03-24 14:56:00-04:00,GWPH,positive
591277.0,The 420 Investor Alan Brochstein On Comments from Syntec Ventures Suggesting Short Report on GW Pharma Will Be Out This Weekend: 'Thesis Appears Very Flawed',2016-03-24 14:52:00-04:00,GWPH,neutral
591278.0,Mid-Afternoon Market Update: US Stocks Turn Positive; TravelCenters of America Shares Drop Following Q4 Results,2016-03-14 14:49:00-04:00,GWPH,positive
591279.0,GW Pharmaceuticals Up 135% After Hitting Two-Year Low Last Week,2016-03-14 13:20:00-04:00,GWPH,negative
591280.0,UPDATE: Cowen & Co On GWPH Epidiolex Results: 'the picture of Epidiolex's efficacy that emerges from this morning's data is a strong one',2016-03-14 12:28:00-04:00,GWPH,positive
591281.0,"Cowen & Co Positive On GWPH's Epidiolex Results, Believes Clinical Development 'Now Substantially Derisked', Maintains Outperform And $135 PT",2016-03-14 12:27:00-04:00,GWPH,positive
591282.0,Mid-Day Market Update: GW Pharma Jumps On Positive Epidiolex Results; Harte Hanks Shares Decline,2016-03-14 12:14:00-04:00,GWPH,positive
591283.0,"The Market In 5 Minutes: Monday, March 14, 2016",2016-03-14 11:24:00-04:00,GWPH,neutral
591284.0,GW Pharma Shares Double Following Positive Epidiolex Trial,2016-03-14 10:14:00-04:00,GWPH,positive
591285.0,Benzinga's Volume Movers,2016-03-14 10:13:00-04:00,GWPH,neutral
591286.0,"Roth Capital Maintains Buy on GW Pharmaceuticals, Raises PT to $160.00",2016-03-14 09:55:00-04:00,GWPH,neutral
591287.0,Mid-Morning Market Update: Markets Open Lower; Apollo Global Management To Acquire Fresh Market For $28.50/Share,2016-03-14 09:52:00-04:00,GWPH,neutral
591288.0,Arena Pharma Moving Higher After Open; Trades Citing Stock as Play on GW Pharma News,2016-03-14 09:34:00-04:00,GWPH,positive
591289.0,10 Stocks Moving In Monday's Pre-Market Session,2016-03-14 08:21:00-04:00,GWPH,neutral
591290.0,UPDATE: GW Pharma +132% Premarket @$89.33 on Positive Epidiolex Results,2016-03-14 08:18:00-04:00,GWPH,positive
591291.0,UPDATE: GW Pharma +95% Premarket @$75.00 on Epidiolex Achieving Primary Endpoint,2016-03-14 07:36:00-04:00,GWPH,neutral
591292.0,GW Pharma +41% Premarket @$54.20 on Positive Epidiolex Results,2016-03-14 07:09:00-04:00,GWPH,positive
591293.0,GW Pharma Announces Primary Endpiont Achieved in Phase 3 Study for Epidiolex,2016-03-14 07:08:00-04:00,GWPH,neutral
591294.0,UPDATE: GW Pharmaceuticals Says Primary Endpoint Achieved With High Statistical Significance,2016-03-14 07:08:00-04:00,GWPH,positive
591295.0,GW Pharmaceuticals Announces Positive Phase 3 Pivotal Study Results for Epidiolex,2016-03-14 07:07:00-04:00,GWPH,positive
591296.0,Benzinga's Top Initiations,2016-03-03 10:01:00-05:00,GWPH,positive
591297.0,Numis Securities Initiates Coverage on GW Pharmaceuticals at Sell,2016-03-03 05:30:00-05:00,GWPH,positive
591298.0,GW Pharma -2.5% Premarket @$39.97; Numis Initiated With Sell Rating,2016-03-03 05:08:00-05:00,GWPH,neutral
591299.0,Report: U.S. Marijuana Market Worth $100 Billion By 2029,2016-02-26 11:55:00-05:00,GWPH,positive
591300.0,Adam Feuerstein @adamfeuerstein $GWPH cancelled presentation at Cowen conf. sked for March 7-9. Reason: Abundance of caution ahead of epidiolex ph3 data release.,2016-02-25 12:05:00-05:00,GWPH,negative
591301.0,15 Marijuana Stocks To Watch In 2015: Where Are They Now?,2016-01-16 18:44:00-05:00,GWPH,neutral
591302.0,"UPDATE: GW Pharma CEO Justin Gover Confirms to Benzinga Trial in Rennes, France that Resulted in 6 Persons Becoming Ill and 1 Coma had No Connection with GW at All, No Implications for the Co",2016-01-15 09:32:00-05:00,GWPH,negative
591303.0,"Cramer Shares His Thoughts On J C Penney, Walgreens Boots Alliance, JetBlue Airways And GW Pharmaceuticals",2016-01-15 07:14:00-05:00,GWPH,positive
591304.0,AFP Reports French Health Ministry Denies Rennes Trial Was for a Cannabis-Based Pain Killer,2016-01-15 06:50:00-05:00,GWPH,negative
591305.0,UPDATE: Ouest France Reports via Sky News that the Drug in Rennes Trial Was for a Cannabis-Based Painkiller; Not Linked as of Yet to Any Particular Company,2016-01-15 06:06:00-05:00,GWPH,neutral
591306.0,Benzinga's Top #PreMarket Losers,2016-01-12 08:27:00-05:00,GWPH,negative
591307.0,"GW Pharmaceuticals Releases Encouraging Epidiolex Data, Shares Rise 5%",2015-12-24 08:37:00-05:00,GWPH,positive
591308.0,Benzinga's Top #PreMarket Gainers,2015-12-24 08:19:00-05:00,GWPH,positive
591309.0,GW Pharmaceuticals +7.3% Premarket @$72 Following Report of Epidiolex Data Published in the Lancet Neurology,2015-12-24 07:23:00-05:00,GWPH,neutral
591310.0,GW Pharmaceuticals Announced Epidiolex Data  Published In The Lancet Neurology,2015-12-24 07:04:00-05:00,GWPH,neutral
591311.0,UPDATE: GW Pharma's Epidiolex Data Published by The Lancet Neurology Shows Reduced Seizure Frequency Across Multiple Drug-Resistant Syndromes,2015-12-24 07:04:00-05:00,GWPH,neutral
591312.0,Shares of GW Pharma Indicated ~$2 Higher Premarket; The 420 Investor's Alan Brochstein Currently Discussing Co. on Benzinga's #PreMarket Prep Show,2015-12-23 09:27:00-05:00,GWPH,positive
591313.0,"Early Global News: Obama Meets Bloomberg, Microsoft Supplying Chinese Government With Windows 10, And More",2015-12-17 07:28:00-05:00,GWPH,neutral
591314.0,"Early Global News: Facebook's LinkedIn Competitor, China's Anti-Dumping Measures, And More",2015-12-10 08:04:00-05:00,GWPH,neutral
591315.0,"Roth Capital's Elemer Piros Reiterates Buy Rating, $130 Target on GW Pharma Following 'Overwhelming Support For Epidiolex'",2015-12-08 08:58:00-05:00,GWPH,positive
591316.0,GW Pharmaceuticals Reports Q4 EPS ($0.071),2015-12-07 16:01:00-05:00,GWPH,neutral
591317.0,GW Pharma Issues New Physician Reports on Epidiolex,2015-12-07 13:01:00-05:00,GWPH,neutral
591318.0,"Early Global News: American Express Expanding In Russia, Baidu To Merge Its Music Business, China Taking Big Steps To Open Market",2015-12-03 07:38:00-05:00,GWPH,neutral
591319.0,"Earnings Scheduled For December 3, 2015",2015-12-03 04:25:00-05:00,GWPH,neutral
591320.0,"Time To Buy GW Pharma, Roth Capital Says",2015-11-30 13:38:00-05:00,GWPH,neutral
591321.0,"Roth Capital Assumes GW Pharmaceuticals at Buy, Announces $130.00 PT",2015-11-30 07:36:00-05:00,GWPH,neutral
591322.0,"Early Global News: Record Online Sales, 400% Jump In Tinder Users, China Experiences Worst Drop In Months",2015-11-27 07:25:00-05:00,GWPH,negative
591323.0,13 Stocks To Watch In The Healthcare Space,2015-10-27 14:38:00-04:00,GWPH,neutral
591324.0,"GW Pharmaceuticals, Otsuka Announce Results from Two Remaining Sativex Phase 3 Cancer Pain Trials; Consistent With Previously Announced Results from Initial Phase 3 Trial, Remaining Trials Fail to Show Superiority Over Placebo",2015-10-27 07:15:00-04:00,GWPH,negative
591325.0,GW Pharmaceuticals and the Government of New South Wales Report a Strategic Agreement to Study Epidiolex and CBDV in a Clinical Trial and Research Program for Children With Epilepsy,2015-10-27 07:06:00-04:00,GWPH,positive
591326.0,8 Stocks Moving On Friday's After-Hours Trading Session,2015-10-17 10:55:00-04:00,GWPH,neutral
591327.0,Shares That Spiked Before Close,2015-10-16 16:02:00-04:00,GWPH,positive
591328.0,GW Pharmaceuticals Finds Sellers At A Familiar Level,2015-09-15 13:11:00-04:00,GWPH,neutral
591329.0,Mid-Morning Market Update: Markets Gain; Gray Television To Buy Schurz Communications' Television And Radio Stations,2015-09-15 11:20:00-04:00,GWPH,positive
591330.0,Benzinga's Volume Movers,2015-09-15 10:30:00-04:00,GWPH,neutral
591331.0,Morning Market Gainers,2015-09-15 09:44:00-04:00,GWPH,neutral
591332.0,"UPDATE: GW Pharma Said Safety Profile for Cannabidiol 'Reassuring,' Showed No Serious Adverse Events",2015-09-15 09:02:00-04:00,GWPH,negative
591333.0,GW Pharma Offers Top-Line Results from Exploratory Phase 2a Placebo-Controlled Trial of Cannabidiol: Showed Positive Proof of Concept Data in Schizophrenia,2015-09-15 09:02:00-04:00,GWPH,positive
591334.0,Can Marijuana Help With Diabetes? Research Is Conflicting,2015-09-14 07:43:00-04:00,GWPH,neutral
591335.0,Is NASDAQ Going Green?,2015-09-01 08:30:00-04:00,GWPH,neutral
591336.0,Marijuana Gains Traction In Fight Against Diabetes And Obesity,2015-08-24 07:38:00-04:00,GWPH,negative
591337.0,Mid-Morning Market Update: Markets Decline; Kohl's Misses Q2 Views,2015-08-13 10:36:00-04:00,GWPH,negative
591338.0,Benzinga's Volume Movers,2015-08-13 10:30:00-04:00,GWPH,neutral
591339.0,Morning Market Gainers,2015-08-13 09:45:00-04:00,GWPH,neutral
591340.0,Benzinga's Top Initiations,2015-08-13 09:31:00-04:00,GWPH,positive
591341.0,Benzinga's Top #PreMarket Gainers,2015-08-13 08:08:00-04:00,GWPH,positive
591342.0,"Morgan Stanley Initiates Coverage on GW Pharmaceuticals at Overweight, Announces $150.00 PT",2015-08-13 04:36:00-04:00,GWPH,negative
591343.0,Is Medical Marijuana Effective?,2015-08-10 07:15:00-04:00,GWPH,positive
591344.0,"Intel, JC Penney, GW Pharma Lead Piper Jaffray's Favorite Ideas",2015-07-07 14:51:00-04:00,GWPH,positive
591345.0,The Tides Are Turning For Marijuana Legalization,2015-06-23 13:15:00-04:00,GWPH,neutral
591346.0,Medical Marijuana Takes A Hit After Supreme Court Ruling,2015-06-16 11:37:00-04:00,GWPH,positive
591347.0,GW Pharma Initiates Second Phase 3 Study of Epidolex,2015-06-11 07:01:00-04:00,GWPH,neutral
591348.0,GW Pharmaceuticals Breaks Out Of 5-Day Trading Range,2015-06-02 14:30:00-04:00,GWPH,neutral
591349.0,Anti-Pot Legalization Group Pushes For More Marijuana Research,2015-05-29 11:03:00-04:00,GWPH,neutral
591350.0,"GW Pharma Reports Co. Names Julian Gangolli as Pres, North America; Co. Relocating CEO Gover to US",2015-05-19 07:02:00-04:00,GWPH,neutral
591351.0,US Stock Futures Edge Higher,2015-05-11 07:54:00-04:00,GWPH,neutral
591352.0,GW Pharmaceuticals Initiates Phase 3 Pivotal Study of Epidiolex (CBD) in Lennox-Gastaut Syndrome,2015-05-11 07:04:00-04:00,GWPH,neutral
591353.0,GW Pharmaceuticals Raising Cash As Pipeline Of Cannabis-Based Drugs Grows,2015-04-29 12:18:00-04:00,GWPH,neutral
591354.0,GW Pharma Announces Proposed Offering of 1.25M ADSs,2015-04-27 16:04:00-04:00,GWPH,neutral
591355.0,"Did The AAN Meeting Affect Biogen, PTC Therapeutics, GW Pharma Or Isis Pharma?",2015-04-27 10:59:00-04:00,GWPH,neutral
591356.0,GW Pharmaceuticals plc Announces US Patent Allowance for Use of Cannabidivarin in Treating Epilepsy,2015-04-27 07:03:00-04:00,GWPH,neutral
591357.0,Shares of GW Pharma Ticking Higher Over Last Few Mins as Hearing BofA Has Increased Price Target Sharply from $115 to $155,2015-04-23 11:24:00-04:00,GWPH,positive
591358.0,GW Pharmaceuticals Begins Second Phase 3 Pivotal Trial for Epidiolex in Dravet Syndrome,2015-04-21 07:04:00-04:00,GWPH,neutral
591359.0,GW Pharmaceuticals Poised For New All-Time High Close On Appropriate Day,2015-04-20 14:30:00-04:00,GWPH,positive
591360.0,Marijuana Stocks Not Very High On 4/20,2015-04-20 13:28:00-04:00,GWPH,neutral
591361.0,Benzinga's Volume Movers,2015-04-14 10:28:00-04:00,GWPH,neutral
591362.0,Morning Market Gainers,2015-04-14 09:42:00-04:00,GWPH,neutral
591363.0,Benzinga's Top #PreMarket Gainers,2015-04-14 08:23:00-04:00,GWPH,positive
591364.0,"GW Pharmaceuticals Shares Rise 7% Premarket Following Release of New Epidiolex Data, PT Raise",2015-04-14 07:28:00-04:00,GWPH,positive
591365.0,"Peel Hunt Raises PT to 530P from 460P on GW Pharmaceuticals, Maintains Hold Rating, According to Reuters",2015-04-14 06:10:00-04:00,GWPH,neutral
591366.0,"GW Pharma, Builders FirstSource Lead Monday's After-Hours Movers",2015-04-13 19:26:00-04:00,GWPH,neutral
591367.0,GW Pharma. Reports New  Epidiolex Data Released by the American Academy of Neurology,2015-04-13 16:09:00-04:00,GWPH,neutral
591368.0,Breakfast Of Champions: Is Pot Good For You?,2015-04-13 12:25:00-04:00,GWPH,positive
591369.0,Marijuana Bill Gains Momentum In Congress,2015-04-01 08:55:00-04:00,GWPH,positive
591370.0,Benzinga's Volume Movers,2015-03-31 10:21:00-04:00,GWPH,neutral
591371.0,Morning Market Gainers,2015-03-31 09:42:00-04:00,GWPH,neutral
591372.0,Benzinga's Top #PreMarket Gainers,2015-03-31 08:14:00-04:00,GWPH,positive
591373.0,GW Pharma Begins Phase 3 Pivotal Trial For Epidiolex In Dravet Syndrome,2015-03-31 07:01:00-04:00,GWPH,neutral
591374.0,The Top 5 Trading Ideas Of The Week By Traffic,2015-03-20 17:32:00-04:00,GWPH,positive
591375.0,The Marijuana CARERS Act: What You Need To Know,2015-03-19 15:12:00-04:00,GWPH,neutral
591376.0,GW Pharmaceuticals Continues To Rally: A Technical Look,2015-03-16 12:01:00-04:00,GWPH,neutral
591377.0,Marijuana: What A Difference Two Decades Makes,2015-03-16 10:12:00-04:00,GWPH,neutral
591378.0,Marijuana Remains The 'Wild West' Of Investing,2015-03-12 11:28:00-04:00,GWPH,neutral
591379.0,18 Biotech Stocks These Wall Street Analysts Are Tracking,2015-03-11 12:04:00-04:00,GWPH,neutral
591380.0,Marijuana Investment: Is It Time?,2015-03-09 12:15:00-04:00,GWPH,neutral
591381.0,"Marijuana A Promising Treatment, But Research And Development Still Limited",2015-03-02 14:51:00-05:00,GWPH,negative
591382.0,5 Marijuana Stocks Getting Investors High (And 7 Key Post-Legalization Stats),2015-02-17 00:50:00-05:00,GWPH,neutral
591383.0,The Marijuana Market Is Expanding: Here Are A Couple Ways To Get Involved,2015-01-23 07:28:00-05:00,GWPH,neutral
591384.0,"GW Pharmaceuticals Opens Lowers, Has Huge Recovery",2015-01-08 13:24:00-05:00,GWPH,positive
591385.0,Benzinga's Volume Movers,2015-01-08 10:33:00-05:00,GWPH,neutral
591386.0,Morning Market Losers,2015-01-08 09:54:00-05:00,GWPH,negative
591387.0,"Pharmaceuticals, Therapeutics And A Retailer On The Move Thursday Morning",2015-01-08 09:00:00-05:00,GWPH,neutral
591388.0,"UPDATE: GW Pharmaceuticals Share Remain Volatile in Premarket, Now Down 3.5% Following Report Sativex Did Not Meet Primary Endpoint in First Trial",2015-01-08 08:59:00-05:00,GWPH,positive
591389.0,GW Pharmaceuticals Falls 7% Following Disappointing Sativex Trial,2015-01-08 08:49:00-05:00,GWPH,negative
591390.0,Benzinga's Top #PreMarket Losers,2015-01-08 08:22:00-05:00,GWPH,negative
591391.0,GW Pharmaceuticals Shares Fall 20% on Resumption of Trade; Sativex Didn't Meet Primary Endpoint in First Trial,2015-01-08 07:34:00-05:00,GWPH,positive
591392.0,GW Pharma Shares to Resume Trade at 7:30 a.m. EST,2015-01-08 07:20:00-05:00,GWPH,positive
591393.0,GW Pharma Issues Update on Epidilex: Expecting Phase 3 Data by End of '15,2015-01-08 07:03:00-05:00,GWPH,neutral
591394.0,Shares of GW Pharma Halted News Pending,2015-01-08 07:00:00-05:00,GWPH,positive
591395.0,15 Marijuana Stocks To Watch In 2015,2015-01-06 11:45:00-05:00,GWPH,neutral
591396.0,CORRECTION -- Pot Stocks Pay Off: Here's How The Marijuana Sector Fared Last Year,2015-01-04 23:12:00-05:00,GWPH,negative
591397.0,59 Financial Experts Just Revealed What 2015 Could Bring,2014-12-30 16:55:00-05:00,GWPH,neutral
591398.0,GW Pharmaceuticals Added to NASDAQ Biotechnology Index,2014-12-22 05:09:00-05:00,GWPH,neutral
591399.0,GW Pharmaceuticals Conference Call Highlights,2014-12-02 17:02:00-05:00,GWPH,neutral
591400.0,"GW Pharma Reports FY14 Sales $48.7M vs $44.3M During 2013, After-Tax Net Loss$23.8M vs $7.4M in '13",2014-12-02 07:05:00-05:00,GWPH,neutral
591401.0,"Earning and Economic Calendar for Tuesday December 2, 2014",2014-12-02 05:47:00-05:00,GWPH,neutral
591402.0,"Earnings Scheduled For December 2, 2014",2014-12-02 05:27:00-05:00,GWPH,neutral
591403.0,"GW Pharmaceuticals to Report Q4, Year-End 2014 Financial Results on December 2, 2014",2014-11-24 05:00:00-05:00,GWPH,neutral
591404.0,GW Pharmaceuticals Begins Phase 2/3 Clinical Trial of Epidiolex for Epilepsy in Dravet Syndrome ,2014-10-30 05:04:00-04:00,GWPH,neutral
591405.0,GW Pharmaceuticals Epidiolex Receives Orphan Designation from EMA for Treatment of Dravet Syndrome ,2014-10-22 05:05:00-04:00,GWPH,neutral
591406.0,Earlier Melissa Lee Tweet Confirms GW Pharma CEO Will Be on CNBC's Fast Money,2014-10-14 14:58:00-04:00,GWPH,neutral
591407.0,Hearing GW Pharma CEO to Appear on CNBC's Fast Money Today,2014-10-14 10:50:00-04:00,GWPH,neutral
591408.0,GW Pharmaceuticals Says Preliminary Topline Results of Phase 2a Ulcerative Colitis Trial Support Further Investigation,2014-10-14 07:04:00-04:00,GWPH,positive
591409.0,GW Pharmaceuticals Announces New Physician Reports of Epidiolex Treatment Effect in Children and Young Adults With Treatment-Resistant Epilepsy ,2014-10-14 07:03:00-04:00,GWPH,neutral
591410.0,U.K. Government Rejects GW Pharmaceuticals PLC's Cannabis Drug,2014-10-08 12:22:00-04:00,GWPH,negative
591411.0,GW Pharma Shares Drop 7% as UK Cost Agency Says Cannabis Drug to Treat MS Not Cost Effective,2014-10-08 09:59:00-04:00,GWPH,positive
591412.0,Morning Market Losers ,2014-10-08 09:48:00-04:00,GWPH,negative
591413.0,Benzinga's Top #PreMarket Losers,2014-10-08 08:09:00-04:00,GWPH,negative
591414.0,#Premarket Prep Technical Update - Consolidation In GW Pharmaceuticals Continues,2014-09-24 12:53:00-04:00,GWPH,neutral
591415.0,"GW Pharmaceuticals to Present at Leerink Rare Disease Roundtable on Wednesday, 1 October, 2014 at 8:25 AM ET.",2014-09-24 05:22:00-04:00,GWPH,neutral
591416.0,GW Pharma Shares Spike Lower to High,2014-09-11 15:05:00-04:00,GWPH,neutral
591417.0,GW Pharma Shares Spike Lower,2014-09-02 11:30:00-04:00,GWPH,neutral
591418.0,3 Pharma Companies Investing In Cannabis-Related Treatments,2014-08-28 10:42:00-04:00,GWPH,neutral
591419.0,"Insys, GW Pharmaceuticals Rise On Short Seller's Comments",2014-08-11 15:24:00-04:00,GWPH,neutral
591420.0,"GW Pharmaceuticals to Report Q3 2014 Financial Results on August 6, 2014 Before the Market Open",2014-07-30 05:20:00-04:00,GWPH,neutral
591421.0,"GW Pharma Shares Move Higher; May be Attributed to Report Rep Scott Introduces Bill to Exclude Therapeutic Hemp, Cannabidiol from Definition of Marijuana ",2014-07-29 09:51:00-04:00,GWPH,positive
591422.0,Getting The Word Out To Cannabis Users: A Chat With BudgetWeed CEO Marlon Fuller,2014-07-15 15:57:00-04:00,GWPH,neutral
591423.0,GW Pharma Shares Spike Higher at Open,2014-07-09 09:32:00-04:00,GWPH,positive
591424.0,UPDATE: GW Pharma Declines Comment on Move in Share Price,2014-07-07 15:44:00-04:00,GWPH,positive
591425.0,"BZ NOTE: GW Pharma Execs Will Be Speaking at Piper Jaffray's Catalyst Symposium, Chair Guy Will Present to Georgia Regents University Students Tuesday",2014-07-07 15:20:00-04:00,GWPH,positive
591426.0,GW Pharma Shares Spike Lower on Volume,2014-07-07 15:14:00-04:00,GWPH,neutral
591427.0,"TheStreet's David Peltier On Investing In Stocks Under $10, Picking Dividends And Apple",2014-07-03 10:09:00-04:00,GWPH,neutral
591428.0,O.pen Vape's Steve Berg: Transparency & Federal Illegality Help Budding Marijuana Industry Succeed,2014-07-03 09:18:00-04:00,GWPH,positive
591429.0,"General Motors Issues More Recalls, Reach 27 Million Autos Recalled In 2014",2014-06-30 15:52:00-04:00,GWPH,positive
591430.0,MannKind Jumps On FDA Approval; Rayonier Shares Slide,2014-06-30 13:58:00-04:00,GWPH,positive
591431.0,Markets Edge Higher; PPG To Acquire Comex For $2.3 Billion,2014-06-30 10:29:00-04:00,GWPH,neutral
591432.0,Benzinga's Volume Movers,2014-06-30 10:26:00-04:00,GWPH,neutral
591433.0,Stocks Hitting 52-Week Highs,2014-06-30 10:16:00-04:00,GWPH,neutral
591434.0,Morning Market Movers ,2014-06-30 09:40:00-04:00,GWPH,neutral
591435.0,Benzinga's Top #PreMarket Gainers,2014-06-30 08:05:00-04:00,GWPH,positive
591436.0,GW Pharmaceuticals Shares Jump Following Price Target Raise,2014-06-30 07:59:00-04:00,GWPH,positive
591437.0,"GW Pharma Shares Cross Above $100 Premarket, as Piper Jaffray Raises PT to $147 from $97",2014-06-30 07:26:00-04:00,GWPH,positive
591438.0,GW Pharma Closes Offering of ADSs,2014-06-25 11:16:00-04:00,GWPH,neutral
591439.0,Melissa Lee Tweet: What a week for $GWPH +16% - positive data on cannabinoid (marijuana) Epidiolex epilepsy treatment. CEO joins @CNBCFastMoney 5p.,2014-06-20 13:05:00-04:00,GWPH,positive
591440.0,Shares of GW Pharma Spike Higher; May be Attributed to Report FDA Studying if DEA to Loosen Restrictions on Marijuana,2014-06-20 10:40:00-04:00,GWPH,positive
591441.0,Cara Therapeutics Share Move Higher on Twitter Mention,2014-06-19 15:30:00-04:00,GWPH,positive
591442.0,GW Pharmaceuticals Prices 1.7M ADS Offering at $86.83/ADS,2014-06-18 19:08:00-04:00,GWPH,neutral
591443.0,GW Pharma To Raise $86 Million In Offering; Shares Down Off All-Time High,2014-06-18 10:09:00-04:00,GWPH,positive
591444.0,Morning Market Losers ,2014-06-18 09:44:00-04:00,GWPH,negative
591445.0,UPDATE: GW Pharma Shares Fall 4% Premarket on 1.7M ADS Offering Announcement,2014-06-18 08:15:00-04:00,GWPH,positive
591446.0,Benzinga's Top #PreMarket Losers,2014-06-18 08:12:00-04:00,GWPH,negative
591447.0,GW Pharma Reports Offering of 1.7M ADSs,2014-06-17 16:08:00-04:00,GWPH,neutral
591448.0,"Mid-Afternoon Market Update: Oil Falls, US Indexes Rise In Afternoon Session",2014-06-17 15:16:00-04:00,GWPH,neutral
591449.0,Mid-Day Market Update: Amira Rises On Upbeat Earnings; Acorda Therapeutics Shares Tumble,2014-06-17 12:41:00-04:00,GWPH,positive
591450.0,#Premarket Prep Technical Update - GW Pharmaceuticals Trading Sharply Higher,2014-06-17 11:57:00-04:00,GWPH,neutral
591451.0,Benzinga's Volume Movers,2014-06-17 10:37:00-04:00,GWPH,neutral
591452.0,Mid-Morning Market Update: Markets Gain; FactSet Posts Rise In Revenue,2014-06-17 10:27:00-04:00,GWPH,positive
591453.0,GW Pharma Shares Move to Highs; Jim Cramer Making Positive Comments on CNBC,2014-06-17 09:56:00-04:00,GWPH,positive
591454.0,Morning Market Movers ,2014-06-17 09:45:00-04:00,GWPH,neutral
591455.0,Benzinga's Top #PreMarket Gainers,2014-06-17 08:10:00-04:00,GWPH,positive
591456.0,UPDATE: GW Pharmaceuticals Shares Rise 10% Premarket Following Release of Positive Report on Epidiolex ,2014-06-17 07:20:00-04:00,GWPH,positive
591457.0,GW Pharmaceuticals Announces Physician Reports of Epidiolex Treatment Effect in Children and Young Adults With Treatment-Resistant Epilepsy From Physician-Led Expanded Access Treatment Program ,2014-06-17 07:03:00-04:00,GWPH,neutral
591458.0,GW Pharma Shares Spike Higher,2014-06-12 12:28:00-04:00,GWPH,positive
591459.0,Mid-Day Market Update: Diamond Foods Shares Fall After Weak Earnings; GW Pharma Gains,2014-06-06 12:37:00-04:00,GWPH,positive
591460.0,Mid-Morning Market Update: Markets Gain On Jobs Data; VeriFone Earnings Beat Estimates,2014-06-06 10:25:00-04:00,GWPH,positive
591461.0,Morning Market Movers ,2014-06-06 09:38:00-04:00,GWPH,neutral
591462.0,Benzinga's Top #PreMarket Gainers,2014-06-06 08:07:00-04:00,GWPH,positive
591463.0,UPDATE: GW Pharmaceuticals Shares Rise 7.5% Premarket Following Announcement of FDA Fast Track Designation for Epidiolex,2014-06-06 07:56:00-04:00,GWPH,positive
591464.0,US Stock Futures Rise; All Eyes On Jobs Report,2014-06-06 07:30:00-04:00,GWPH,neutral
591465.0,GW Pharmaceuticals Epidiolex(R) Receives Fast Track Designation From FDA for Treatment of Dravet Syndrome ,2014-06-06 05:24:00-04:00,GWPH,neutral
591466.0,UPDATE: Spike in GW Pharma Share Price May be Attributed to Premarket Report Being Circulated Now Mentioning NY State to Investigate Marijuana Extract Use for Childhood Epilepsy,2014-06-03 10:44:00-04:00,GWPH,positive
591467.0,GW Pharma Shares Spike Higher,2014-06-03 10:40:00-04:00,GWPH,positive
591468.0,Finding Value In The Burned Marijuana Sector ,2014-05-29 10:13:00-04:00,GWPH,positive
591469.0,So-Called Marijuana Stock VPCO Up-Lists Onto Major Exchange ,2014-05-29 09:07:00-04:00,GWPH,neutral
591470.0,GW Pharma Shares Move Higher; May be Attributed to Tuesday Atlanta Business Chronicle Being Circulated,2014-05-28 14:36:00-04:00,GWPH,positive
591471.0,Remaining Vigilant Is Key For Marijuana Investors ,2014-05-27 16:38:00-04:00,GWPH,positive
591472.0,GW Pharma Shares Move Higher; May be Attributed to Positive Najarian Comments on CNBC,2014-05-22 12:59:00-04:00,GWPH,positive
591473.0,GW Pharmaceuticals Shares Move Higher After-Hours on CEO Appearance on CNBC,2014-05-14 17:53:00-04:00,GWPH,positive
591474.0,CannabisFN Weekly: Stocks Move Lower As Valuations Start To Normalize,2014-05-13 15:47:00-04:00,GWPH,negative
591475.0,Filing from GW Pharma Shows Registration for Automatic ADS Securities Shelf,2014-05-07 07:54:00-04:00,GWPH,positive
591476.0,US Stock Futures Edge Higher Ahead Of Productivity Data ,2014-05-07 07:28:00-04:00,GWPH,neutral
591477.0,FDA Accepts IND from GW Pharmaceuticals  for Phase 2/3 Clinical Trial of Epidiolex in Treatment of Dravet Syndrome ,2014-05-07 05:39:00-04:00,GWPH,positive
591478.0,GW Pharma Reports Q2 EPS of $(0.04) vs $(0.48) Est; Revenue of $12.60M vs $12.48M Est,2014-05-07 05:34:00-04:00,GWPH,neutral
591479.0,GW Pharmaceuticals Reports Q2 2014 Financial Results and Operational Progress ,2014-05-07 05:32:00-04:00,GWPH,positive
591480.0,GW Pharma Shares Move Higher; May be Attributed to Positive Navellier Comments,2014-05-06 13:03:00-04:00,GWPH,positive
591481.0,"GW Pharmaceuticals Names Dr. Kenneth Sommerville VP, Clinical Science ",2014-05-06 05:30:00-04:00,GWPH,neutral
591482.0,Morning Market Movers ,2014-05-05 09:45:00-04:00,GWPH,neutral
591483.0,Benzinga's Top #PreMarket Gainers,2014-05-05 08:09:00-04:00,GWPH,positive
591485.0,Marijuana Sector Trying To Hold This Week's Retest Of Recent Lows,2014-04-29 16:27:00-04:00,GWPH,negative
591486.0,Spike in GW Pharmaceuticals May be Attributed to Jim Cramer Comments on CNBC,2014-04-29 09:58:00-04:00,GWPH,neutral
591487.0,GW Pharma Spikes Higher,2014-04-29 09:57:00-04:00,GWPH,neutral
591488.0,Morning Market Movers ,2014-04-28 09:43:00-04:00,GWPH,neutral
591489.0,Benzinga's Top #PreMarket Gainers,2014-04-28 08:05:00-04:00,GWPH,positive
591490.0,US Stock Futures Gain Ahead Of Home Sales Report,2014-04-28 07:27:00-04:00,GWPH,positive
591491.0,UPDATE: GW Pharmaceuticals Shares Rise 12% Premarket Following Announcement of FDA Fast Track Designation for Sativex,2014-04-28 07:06:00-04:00,GWPH,positive
591492.0,GW Pharmaceuticals Sativex Receives Fast Track Designation from FDA,2014-04-28 05:43:00-04:00,GWPH,neutral
591493.0,"Infitialis Tweet: '$GWPH is a shareholder dilution machine. Since 2001 reverse-merger, shares outstanding increased 139.8% with limited business achievement'",2014-04-25 09:18:00-04:00,GWPH,positive
591494.0,Morning Market Movers ,2014-04-23 09:44:00-04:00,GWPH,neutral
591495.0,GW Pharmaceuticals Kicks Back Up After Morgan Stanley Buys The Bottom,2014-04-22 14:52:00-04:00,GWPH,neutral
591496.0,#Premarket Technical Update - GW Pharmaceuticals Trading Sharply Higher,2014-04-22 12:04:00-04:00,GWPH,neutral
591497.0,"Citron's Andrew Left, Following Up with Benzinga on his Medbox Tweet, GWPH is a Real Company, Medbox is a Complete Scam",2014-04-22 10:18:00-04:00,GWPH,negative
591498.0,"GW Pharma Soars 35% on Initiation from Morgan Stanley, Bullish Comments by Jim Cramer",2014-04-22 10:06:00-04:00,GWPH,neutral
591499.0,GW Pharma Shares Spiking to Session Highs as Jim Cramer Highlighting the Play on CNBC,2014-04-22 09:57:00-04:00,GWPH,positive
591500.0,"Morgan Stanley Initiates Coverage on GW Pharma at Overweight, Announces $103.00 PT",2014-04-22 07:53:00-04:00,GWPH,negative
591501.0,A Look At 2014's Leading Cannabis Stocks (Part I),2014-04-21 15:52:00-04:00,GWPH,neutral
591502.0,#Premarket Prep Technical Update - GW Pharmaceuticals Finds Resistance,2014-03-31 14:36:00-04:00,GWPH,neutral
591503.0,GW Pharmaceutical's Upcoming Epidiolex Data Has Relatively Low Bar for Success ,2014-03-26 06:57:00-04:00,GWPH,positive
591504.0,A Closer Look At Marijuana Stocks With Alan Brochstein,2014-03-24 10:23:00-04:00,GWPH,neutral
591505.0,420 Investor Alan Brochstein: United States Has Led A Failed War On Drugs,2014-03-17 13:46:00-04:00,GWPH,negative
591506.0,GW Pharmaceuticals Provides Update on Cannabinoid Pipeline ,2014-03-17 05:36:00-04:00,GWPH,neutral
591507.0,Benzinga's Top Initiations,2014-03-11 08:37:00-04:00,GWPH,positive
591508.0,"Bank of America Initiates Coverage on GW Pharma at Buy, Announces $93.00 PT",2014-03-11 07:08:00-04:00,GWPH,neutral
591509.0,"Jim Cramer Tweets: 'Oh Lordy, Merrill starts cannabis king $GWPH with a buy! Going to the mainsteet.com MJ index to watch today's action.'",2014-03-11 07:03:00-04:00,GWPH,neutral
591510.0,GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome,2014-02-28 08:01:00-05:00,GWPH,neutral
591511.0, GW Pharmaceuticals Franted FDA Orphan Drug Designation For Epidiolex In The Treatment Of Lennox-Gastaut Syndrome,2014-02-28 08:01:00-05:00,GWPH,neutral
591512.0,3 Things That Could Extinguish The 'Reefer Rally',2014-02-24 16:37:00-05:00,GWPH,neutral
591513.0,GW Pharmaceuticals Shares Dropping; May be Attributed to Infitialis Seeking Alpha Post,2014-02-20 10:08:00-05:00,GWPH,positive
591514.0,"Piper Sees ""Meaningful Utility"" from GW Phamaceuticals CBD, Reiterates Overweight Rating",2014-02-07 16:18:00-05:00,GWPH,negative
591515.0,GW Pharma Shares Getting a Pop as Piper Jaffray Boosts Target from $77 to $97,2014-02-07 11:15:00-05:00,GWPH,positive
591516.0,"Leerink Swann Initiates Coverage on GW Pharma at Outperform, Announces $79 Price Target",2014-02-04 08:08:00-05:00,GWPH,neutral
591517.0,Benzinga's Top #PreMarket Losers,2014-01-27 08:20:00-05:00,GWPH,negative
591518.0,Benzinga's Volume Movers,2014-01-09 10:28:00-05:00,GWPH,neutral
591519.0,GW Pharmaceuticals Prices 2.44M ADS Offering at $36.00/ADS,2014-01-09 06:05:00-05:00,GWPH,neutral
591520.0,Mid-Day Market Update: Infoblox Tumbles On Weak Guidance; GW Pharma Shares Jump,2013-11-27 12:19:00-05:00,GWPH,negative
591521.0,Benzinga's Volume Movers,2013-11-27 10:47:00-05:00,GWPH,neutral
591522.0,UPDATE: Piper Jaffray Initiates Coverage on GW Pharmaceuticals on Expected Attractive Returns,2013-11-27 10:46:00-05:00,GWPH,positive
591523.0,Mid-Morning Market Update: Markets Open Higher; Hewlett-Packard Profit Beats Estimates,2013-11-27 10:30:00-05:00,GWPH,positive
591524.0,Benzinga's Top #PreMarket Gainers,2013-11-27 08:24:00-05:00,GWPH,positive
591525.0,"Piper Jaffray Initiates Coverage on GW Pharma at Overweight, Announces $73.00 PT",2013-11-26 16:15:00-05:00,GWPH,negative
591526.0,Cannabis Stock Analyst Talks About High Revenue Potential,2013-11-15 16:08:00-05:00,GWPH,neutral
591527.0,GW Pharmaceuticals Initiates Phase 1b/2a Clinical Trial for GBM,2013-11-11 06:23:00-05:00,GWPH,neutral
591528.0,UPDATE: GW Pharmaceuticals Spike May be Attributed to Article Posted in Medical Jane Monday: 'Cannabinoids May Combine To Effectively Treat Cancer',2013-10-15 10:59:00-04:00,GWPH,positive
591529.0,GW Pharmaceuticals Shares Moving Higher; May be Attributed to Abstract in Anticancer Research,2013-10-15 10:53:00-04:00,GWPH,positive
591530.0,Morning Market Movers ,2013-10-07 10:03:00-04:00,GWPH,neutral
591531.0,Benzinga's Top Pre-Market Gainers,2013-10-07 08:07:00-04:00,GWPH,positive
591532.0,GW Pharmaceuticals Announces Agreement on Sativex Pricing in Germany ,2013-09-23 06:45:00-04:00,GWPH,positive
591533.0,Morning Market Losers ,2013-09-09 10:09:00-04:00,GWPH,negative
591534.0,GW Pharma Reports Q3 EPS of $(0.02) vs $(0.11) Est; Revenue of $11.04M vs $10.71M Est,2013-08-05 05:52:00-04:00,GWPH,neutral
591535.0," Canaccord Initiates Coverage on GW Pharma at Buy, Announces $13.00 PT",2013-06-04 08:51:00-04:00,GWPH,neutral
